F344/DuCrl |
change in blood insulin level |
fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) |
Galli J, et al., NatGenet 1996 Jan;12(1):31-7. |
blood insulin amount |
not specified |
65 days
| 3 |
|
2.4 |
mU/l |
8.0 |
13.86 |
enzyme linked immunosorbent assay |
|
0 |
glucose injection |
120 |
min |
|
|
|
11400 |
82 |
SHR/Fub |
urine albumin excretion rate |
controlled sodium content diet (0.2 %) |
Poyan Mehr A, et al., Physiol Genomics 2003 Aug 15;14(3):209-16. |
urine albumin amount |
not specified |
98 days
| 6 |
|
1.65 |
mg/d |
|
|
enzyme linked immunosorbent assay |
urine |
0.0 |
|
0 |
|
rat albumin ELISA |
|
|
13280 |
335 |
OLETF |
serum leptin level |
fasting (for 18 hours) |
Ogino T, et al., Mamm Genome 2003 Dec;14(12):839-44. |
blood leptin amount |
male |
246 days
| 23 |
|
10.87 |
ng/ml |
0.57 |
2.71 |
enzyme linked immunosorbent assay |
carotid artery |
0 |
|
0 |
|
immunoreactive leptin kit; Morinaga Institute of Biological Science, Yokohama, Japan |
|
|
65739 |
248 |
F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj |
serum leptin level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood leptin amount |
male |
211 days
| 11 |
|
5.82 |
ng/ml |
0.59 |
1.96 |
enzyme linked immunosorbent assay |
|
0.0 |
oral glucose |
7 |
days |
ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) |
|
|
67486 |
311 |
MWF-Chr 6SHR/Rkb |
urine albumin excretion rate |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
urine albumin amount |
not specified |
56 days
| 19 |
|
0.7 |
mg/d |
0.1 |
0.44 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
65272 |
117 |
BN/Crl |
plasma corticosterone level |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
blood corticosterone amount |
male |
60 days
| 6 |
|
283.0 |
ng/ml |
30.0 |
73.48 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68788 |
1012 |
GK/Ox |
plasma insulin level |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
blood insulin amount |
male |
60 days
| 6 |
|
18.8 |
mU/l |
2.39 |
5.86 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68778 |
1012 |
BN/Crl |
plasma growth hormone level |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
blood growth hormone amount |
male |
60 days
| 6 |
|
59.0 |
ng/ml |
10.0 |
24.49 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68780 |
1012 |
BN/Crl |
plasma growth hormone level |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
blood growth hormone amount |
female |
60 days
| 6 |
|
101.0 |
ng/ml |
5.0 |
12.25 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68781 |
1012 |
SS/Jr |
urine albumin excretion rate |
controlled sodium content diet (0.2 %) |
Poyan Mehr A, et al., Physiol Genomics 2003 Aug 15;14(3):209-16. |
urine albumin amount |
not specified |
56 days
| 12 |
|
69.96 |
mg/d |
|
|
enzyme linked immunosorbent assay |
urine |
0.0 |
|
0 |
|
rat albumin ELISA |
|
|
67824 |
335 |
DA/BklArbNsi |
inflammatory exudate leukotriene B4 level to lipoxin A4 level ratio |
room temperature (14 ml) (for 3 days) then room temperature (10 ml) (for 3 days) then carrageenan (1 ml) (for 6 hours) |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
eicosanoid amount |
female |
56 days-98 days |
9 |
|
9.6 |
null |
|
|
enzyme linked immunosorbent assay |
subcutaneous interscapular cavity |
0.0 |
|
0 |
|
|
inflammatory exudate LTB4 to LXA4 ratio |
|
68410 |
332 |
SHR/FubRkb |
urine albumin excretion rate |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
urine albumin amount |
female |
56 days
| 0 |
|
0.1 |
mg/d |
0.01 |
|
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
69945 |
309 |
SHR/Fub |
urine albumin excretion rate |
control condition |
Schulz A, et al., J Am Soc Nephrol 2003 Dec;14(12):3081-9. |
urine albumin amount |
male |
98 days
| 8 |
|
0.62 |
mg/d |
0.05 |
0.13 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
70169 |
325 |
Crl:WI(Han) |
plasma insulin level |
sham surgical control condition (for 24 days) |
Apaijai N, et al., Biosci Rep. 2017 Oct 17;37(5). pii: BSR20170886. doi: 10.1042/BSR20170886. Print 2017 Oct 31. |
blood insulin amount |
female |
87 days
| 6 |
|
221.0 |
mU/l |
44.2 |
108.27 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
103761 |
2782 |
SS-Leprem2Mcwi |
plasma insulin level |
control condition |
McPherson KC, et al., Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F793-F804. doi: 10.1152/ajprenal.00590.2015. Epub 2016 Jul 27. |
blood insulin amount |
male |
42 days
| 5 |
|
122.2 |
mU/l |
2.6 |
5.81 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
100092 |
2418 |
Jcl:WI |
serum adiponectin level |
control condition |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood adiponectin amount |
male |
52 days
| 6 |
|
14.52 |
ng/ml |
1.36 |
3.33 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
103940 |
2884 |
GK/Jcl |
liver triglyceride level |
control condition |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
liver triglyceride amount |
male |
52 days
| 6 |
|
16.41 |
mg/g |
1.38 |
3.38 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
103971 |
2884 |
SD |
heart left ventricle interstitial norepinephrine level during a period of time |
artificial aortocaval fistula (for 105 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle interstitial norepinephrine amount |
male |
175 days
| 10 |
|
10.2 |
pg/hr |
1.0 |
3.16 |
enzyme linked immunosorbent assay |
|
0.0 |
ACF |
105 |
days |
|
heart left ventricle interstitial bradykinin level during a period of time |
|
99270 |
2278 |
SD |
plasma epinephrine level |
sham surgical control condition (for 105 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
blood epinephrine amount |
male |
175 days
| 8 |
|
75.0 |
pg/ml |
6.0 |
16.97 |
enzyme linked immunosorbent assay |
|
0.0 |
sham ACF |
105 |
days |
|
|
|
99289 |
2278 |
SS/JrHsdMcwi |
plasma leptin level |
control condition |
McPherson KC, et al., Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F793-F804. doi: 10.1152/ajprenal.00590.2015. Epub 2016 Jul 27. |
blood leptin amount |
male |
42 days
| 5 |
|
2.1 |
ng/ml |
0.4 |
0.89 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
100071 |
2418 |
SD-Lepem1Sage-/- |
plasma insulin level |
fasting (for 4 hours) |
D'souza AM, et al., Endocrinology. 2014 Apr;155(4):1268-79. doi: 10.1210/en.2013-1523. Epub 2014 Jan 27. |
blood insulin amount |
female |
42 days
| 6 |
|
971.88 |
mU/l |
99.84 |
244.56 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
104457 |
2949 |
SD |
serum interleukin-4 level |
vehicle control condition then acetic acid (for 0 hours) then physical restraint in tube type rodent restrainer (for 2 hours) then fasting (for 1 days) |
Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. |
blood interleukin-4 amount |
not specified |
0 days
| 4 |
|
0.14 |
ug/l |
0.01 |
0.01 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
error not defined |
|
105411 |
3015 |
SD |
serum interleukin-4 level |
acetic acid (for 0 hours) then physical restraint in tube type rodent restrainer (for 2 hours) then fasting (for 1 days) |
Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. |
blood interleukin-4 amount |
not specified |
0 days
| 12 |
|
0.05 |
ug/l |
0.0 |
0.01 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
error not defined |
|
105412 |
3015 |
SD |
serum interleukin-9 level |
acetic acid (for 0 hours) then physical restraint in tube type rodent restrainer (for 2 hours) then fasting (for 1 days) |
Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. |
blood interleukin-9 amount |
not specified |
0 days
| 12 |
|
0.21 |
ug/l |
0.0 |
0.01 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
error not defined |
|
105417 |
3015 |
SD |
intestine trypsin level |
acetic acid (for 0 hours) then physical restraint in tube type rodent restrainer (for 2 hours) then fasting (for 1 days) |
Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. |
intestine trypsin amount |
not specified |
0 days
| 12 |
|
0.11 |
ug/l |
0.0 |
0.01 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
error not defined |
|
105420 |
3015 |
SD |
intestine trypsin level |
acetic acid (for 0 hours) then physical restraint in tube type rodent restrainer (for 2 hours) then fasting (for 1 days) |
Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. |
intestine trypsin amount |
not specified |
0 days
| 12 |
|
0.23 |
ug/l |
0.01 |
0.02 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
error not defined |
|
105421 |
3015 |
BUF/SimRijHsd |
number of individuals in a study population displaying Haemophilus H35 infection at a point in time |
Haemophilus |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
not specified |
70 days-84 days |
8 |
|
4.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108603 |
3072 |
WAG/RijHfr |
number of individuals in a study population displaying Pasteurella pneumotropica infection at a point in time |
Haemophilus |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
not specified |
70 days-84 days |
8 |
|
2.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108610 |
3072 |
BDIX/Han |
number of individuals in a study population displaying Haemophilus H21 infection at a point in time |
housing in trios (for 42 days) and housing with Haemophilus H21-infected subject (for 42 days) |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
female |
70 days-84 days |
6 |
|
4.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
pathogen |
42 |
days |
|
|
|
108616 |
3072 |
BN/OrlIcoCrlf |
number of individuals in a study population displaying Haemophilus H21 infection at a point in time |
housing in trios (for 42 days) and housing with Haemophilus H21-infected subject (for 42 days) |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
female |
70 days-84 days |
6 |
|
6.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
pathogen |
42 |
days |
|
|
|
108617 |
3072 |
BN/OrlIcoCrlf |
number of individuals in a study population displaying Pasteurella pneumotropica infection at a point in time |
housing in trios (for 42 days) and housing with Pasteurella pneumotropica-infected subject (for 42 days) |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
female |
70 days-84 days |
6 |
|
6.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
pathogen |
42 |
days |
|
|
|
108627 |
3072 |
GK |
plasma leptin level |
resting (for 42 days) |
Kupai K, et al., Diabetol Metab Syndr. 2015 Oct 6;7:85. doi: 10.1186/s13098-015-0080-x. eCollection 2015. |
blood leptin amount |
male |
0 days
| 20 |
|
0.19 |
ng/ml |
0.01 |
0.03 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
109899 |
3160 |
MWF/FubRkb |
urine albumin excretion rate |
vehicle control condition (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
urine albumin amount |
male |
114 days
| 10 |
|
64.4 |
mg/d |
5.6 |
17.71 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
109405 |
3140 |
Crl:WI |
urine albumin excretion rate |
finerenone (10 null) (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
urine albumin amount |
male |
114 days
| 10 |
|
37.8 |
mg/d |
3.8 |
12.02 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
109406 |
3140 |
BRAT-Avpdi/BluHsd |
kidney cortex hyaluronic acid level |
desmopressin (100 ug/kg) (for 2 days) |
Ivanova LN, et al., Exp Physiol. 2013 Nov;98(11):1608-19. doi: 10.1113/expphysiol.2013.073163. Epub 2013 Aug 16. |
kidney molecular composition trait |
not specified |
0 days
| 5 |
|
0.6 |
mg/g |
0.1 |
0.22 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
107215 |
3078 |
SHR/FubRkb |
urine albumin excretion rate |
sham surgical control condition (for 42 days) |
Schulz A, etal., Physiol Genomics. 2012 Jan 18;44(1):110-6. Epub 2011 Nov 22. |
urine albumin amount |
male |
168 days
| 9 |
|
1.3 |
mg/d |
0.3 |
0.9 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
109561 |
3148 |
MWF/FubRkb |
urine albumin excretion rate |
sham surgical control condition |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
urine albumin amount |
male |
84 days
| 10 |
|
22.8 |
mg/d |
2.1 |
6.64 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108123 |
3116 |
GK/MolTac |
serum insulin level |
control condition |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood insulin amount |
female |
420 days
| 11 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
fasting insulin, non fasting insulin |
106919 |
3071 |
WKY/NMolTac |
serum insulin level |
control condition |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood insulin amount |
female |
60 days
| 6 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
fasting insulin, non fasting insulin |
106920 |
3071 |
WKY/NMolTac |
serum insulin level |
control condition |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood insulin amount |
female |
420 days
| 9 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
fasting insulin, non fasting insulin |
106922 |
3071 |
WKY/NMolTac |
serum insulin level |
fasting (for 6 hours) |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood insulin amount |
female |
60 days
| 6 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
fasting insulin, non fasting insulin |
106926 |
3071 |
LEW/HanHfr |
number of individuals in a study population displaying Pasteurella pneumotropica infection at a point in time |
Haemophilus |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
not specified |
70 days-84 days |
8 |
|
3.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108609 |
3072 |
WKY/NIcoCrlf |
number of individuals in a study population displaying Haemophilus H21 infection at a point in time |
housing in trios (for 42 days) and housing with Haemophilus H21-infected subject (for 42 days) |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
female |
70 days-84 days |
6 |
|
6.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
pathogen |
42 |
days |
|
|
|
108620 |
3072 |
LEW/Crl |
number of individuals in a study population displaying Pasteurella pneumotropica infection at a point in time |
housing in trios (for 42 days) and housing with Pasteurella pneumotropica-infected subject (for 42 days) |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
female |
70 days-84 days |
6 |
|
1.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
pathogen |
42 |
days |
|
|
|
108629 |
3072 |
WKY/NIcoCrlf |
number of individuals in a study population displaying Pasteurella pneumotropica infection at a point in time |
housing in trios (for 42 days) and housing with Pasteurella pneumotropica-infected subject (for 42 days) |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
female |
70 days-84 days |
6 |
|
6.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
pathogen |
42 |
days |
|
|
|
108630 |
3072 |
W/Jpe |
urine 8-hydroxy-2'-deoxyguanosine level |
fasting (for 15 hours) |
Sena CM, etal., Int J Mol Sci. 2018 Sep 11;19(9). pii: ijms19092706. doi: 10.3390/ijms19092706. |
urine molecular composition trait |
male |
540 days
| 7 |
|
149.28 |
ng/d |
17.0 |
44.98 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
110926 |
3193 |
WAG/RijHfr |
number of individuals in a study population displaying Haemophilus H21 infection at a point in time |
Haemophilus |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
not specified |
70 days-84 days |
8 |
|
4.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
107797 |
3072 |
GK |
plasma insulin level |
fasting (for 16 hours) |
Weng S, etal., Obes Surg. 2017 Mar;27(3):657-664. doi: 10.1007/s11695-016-2320-z. |
blood insulin amount |
male |
77 days
| 10 |
|
11.7 |
mU/l |
0.16 |
0.52 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
plasma glucagon-like peptide 1 level (CMO:0003638) |
|
109085 |
3111 |
GK |
plasma gastric inhibitory polypeptide level |
fasting (for 16 hours) |
Weng S, etal., Obes Surg. 2017 Mar;27(3):657-664. doi: 10.1007/s11695-016-2320-z. |
blood gastric inhibitory polypeptide amount |
male |
77 days
| 10 |
|
10.87 |
pg/ml |
1.83 |
5.78 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
plasma gastric inhibitory polypeptide level (CMO:0003641) |
|
109087 |
3111 |
GK |
plasma gastric inhibitory polypeptide level |
fasting (for 16 hours) |
Weng S, etal., Obes Surg. 2017 Mar;27(3):657-664. doi: 10.1007/s11695-016-2320-z. |
blood gastric inhibitory polypeptide amount |
male |
77 days
| 10 |
|
6.59 |
pg/ml |
0.67 |
2.11 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
plasma gastric inhibitory polypeptide level (CMO:0003641) |
|
109088 |
3111 |
BRAT-Avpdi/BluHsd |
kidney cortex hyaluronic acid level |
sodium chloride solution (1 ml) (for 2 days) |
Ivanova LN, et al., Exp Physiol. 2013 Nov;98(11):1608-19. doi: 10.1113/expphysiol.2013.073163. Epub 2013 Aug 16. |
kidney molecular composition trait |
not specified |
0 days
| 4 |
|
0.9 |
mg/g |
0.3 |
0.6 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
107212 |
3078 |
GK/Jcl |
serum insulin level |
fasting then glucose solution (2 g/kg) (for 0.5 hours) |
Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5. |
blood insulin amount |
male |
140 days
| 7 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
glucose |
30 |
min |
|
|
|
110219 |
3167 |
WKY/NCrl |
urine albumin excretion rate |
control condition |
Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. |
urine albumin amount |
male |
84 days
| 10 |
|
0.2 |
mg/d |
0.1 |
0.32 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
109284 |
3141 |
SHR/FubRkb |
urine albumin excretion rate |
sham surgical control condition |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
urine albumin amount |
male |
84 days
| 10 |
|
0.4 |
mg/d |
0.1 |
0.32 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108125 |
3116 |
SHR-Chr 6MWF/Rkb |
urine albumin excretion rate |
sham surgical control condition |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
urine albumin amount |
male |
84 days
| 10 |
|
1.3 |
mg/d |
0.3 |
0.95 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108126 |
3116 |
SHR/FubRkb |
urine albumin excretion rate |
control condition |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
urine albumin amount |
male |
84 days
| 8 |
|
0.5 |
mg/d |
0.1 |
0.28 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108141 |
3116 |
HsdCpb:WU |
urine albumin excretion rate |
left nephrectomy (for 84 days) |
Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. |
urine albumin amount |
not specified |
84 days
| 15 |
|
26.0 |
mg/d |
9.9 |
38.34 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
109660 |
3149 |
WAG/Nov |
kidney papilla hyaluronic acid level |
sodium chloride solution (1 ml) (for 2 days) |
Ivanova LN, et al., Exp Physiol. 2013 Nov;98(11):1608-19. doi: 10.1113/expphysiol.2013.073163. Epub 2013 Aug 16. |
kidney molecular composition trait |
not specified |
0 days
| 4 |
|
7.9 |
mg/g |
0.8 |
1.6 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
107216 |
3078 |
BRAT-Avpdi/BluHsd |
kidney papilla hyaluronic acid level |
sodium chloride solution (1 ml) (for 2 days) |
Ivanova LN, et al., Exp Physiol. 2013 Nov;98(11):1608-19. doi: 10.1113/expphysiol.2013.073163. Epub 2013 Aug 16. |
kidney molecular composition trait |
not specified |
0 days
| 4 |
|
4.3 |
mg/g |
0.3 |
0.6 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
107217 |
3078 |
WAG/Nov |
kidney papilla hyaluronic acid level |
desmopressin (100 ug/kg) (for 2 days) |
Ivanova LN, et al., Exp Physiol. 2013 Nov;98(11):1608-19. doi: 10.1113/expphysiol.2013.073163. Epub 2013 Aug 16. |
kidney molecular composition trait |
not specified |
0 days
| 4 |
|
3.29 |
mg/g |
0.24 |
0.48 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
107219 |
3078 |
MWF-Chr 8SHR/Rkb |
urine albumin excretion rate |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
urine albumin amount |
male |
56 days
| 20 |
|
2.6 |
mg/d |
0.6 |
2.68 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108964 |
3133 |
MWF/FubRkb |
urine albumin excretion rate |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
urine albumin amount |
male |
56 days
| 18 |
|
18.1 |
mg/d |
2.0 |
8.49 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108965 |
3133 |
SHR/FubRkb |
urine albumin excretion rate |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
urine albumin amount |
male |
56 days
| 10 |
|
0.3 |
mg/d |
0.1 |
0.32 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108966 |
3133 |
MWF-Chr 8SHR/Rkb |
urine albumin excretion rate |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
urine albumin amount |
female |
56 days
| 20 |
|
0.4 |
mg/d |
0.1 |
0.45 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108968 |
3133 |
Hsd:SD |
plasma plasminogen activator inhibitor 1 level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood plasminogen activator inhibitor 1 amount |
male |
448 days
| 9 |
|
9.31 |
ng/ml |
0.79 |
2.37 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
138306 |
3201 |
Hsd:SD |
blood fibrinogen level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
fibrin formation trait |
male |
448 days
| 9 |
|
3.14 |
mg/ml |
0.13 |
0.39 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
138310 |
3201 |
Hsd:SD |
blood fibrinogen level |
controlled fat content diet (42 %) (for 364 days) |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
fibrin formation trait |
male |
448 days
| 10 |
|
3.08 |
mg/ml |
0.09 |
0.28 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
138312 |
3201 |
SD-Ldlrem1Sage |
plasma leptin level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood leptin amount |
male |
448 days
| 8 |
|
28.18 |
ng/ml |
4.14 |
11.71 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
138315 |
3201 |
SD-Ldlrem1Sage |
plasma adiponectin level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood adiponectin amount |
male |
448 days
| 8 |
|
48.4 |
ug/ml |
5.6 |
15.84 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
138319 |
3201 |
SD-Ldlrem1Sage |
plasma adiponectin level |
controlled fat content diet (42 %) (for 364 days) |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood adiponectin amount |
male |
448 days
| 16 |
|
58.27 |
ug/ml |
7.02 |
28.08 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
138321 |
3201 |
GK/KyoSwe |
change in blood insulin level |
fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) |
Galli J, et al., NatGenet 1996 Jan;12(1):31-7. |
blood insulin amount |
not specified |
65 days
| 4 |
|
8.8 |
mU/l |
4.4 |
8.8 |
enzyme linked immunosorbent assay |
|
|
glucose injection |
120 |
min |
|
change from baseline |
|
11391 |
82 |
DA/Bkl |
calculated serum anti-rat type 2 collagen autoantibody titer |
type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) |
Griffiths MM, et al., Arthritis Rheum 2000 Jun;43(6):1278-89 |
blood autoantibody amount |
both |
66 days-126 days |
105 |
|
15.0 |
null |
0.59 |
6.0 |
enzyme linked immunosorbent assay |
|
0.0 |
immunized |
10 |
days |
variable |
titer |
|
69963 |
850 |
MWF-Chr 6SHR/Rkb |
urine albumin excretion rate |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
urine albumin amount |
female |
168 days
| 0 |
|
1.7 |
mg/d |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
69946 |
309 |
MWF/FubRkb |
urine albumin excretion rate |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
urine albumin amount |
female |
168 days
| 0 |
|
24.0 |
mg/d |
5.5 |
|
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68185 |
309 |
BB/OK |
serum insulin level |
control condition |
Kloting N, et al., Obes Res 2005 Mar;13(3):589-95. |
blood insulin amount |
male |
224 days
| 20 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
ng/ml |
|
67939 |
227 |
SD |
plasma epinephrine level |
artificial aortocaval fistula (for 105 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
blood epinephrine amount |
male |
175 days
| 10 |
|
101.0 |
pg/ml |
11.0 |
34.79 |
enzyme linked immunosorbent assay |
|
0.0 |
ACF |
105 |
days |
|
|
|
99290 |
2278 |
Crl:WI(Han) |
plasma estradiol level |
bilateral ovariectomy (for 24 days) |
Apaijai N, et al., Biosci Rep. 2017 Oct 17;37(5). pii: BSR20170886. doi: 10.1042/BSR20170886. Print 2017 Oct 31. |
blood estradiol amount |
female |
87 days
| 6 |
|
26.6 |
pg/ml |
2.6 |
6.37 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
103774 |
2782 |
SHR/Fub |
urine albumin excretion rate |
controlled sodium content diet (0.2 %) |
Poyan Mehr A, et al., Physiol Genomics 2003 Aug 15;14(3):209-16. |
urine albumin amount |
not specified |
196 days
| 11 |
|
2.6 |
mg/d |
|
|
enzyme linked immunosorbent assay |
urine |
0.0 |
|
0 |
|
rat albumin ELISA |
|
|
13285 |
335 |
F344/NRrrc |
serum leptin level |
fasting (for 18 hours) |
Ogino T, et al., Mamm Genome 2003 Dec;14(12):839-44. |
blood leptin amount |
male |
246 days
| 21 |
|
6.83 |
ng/ml |
0.24 |
1.09 |
enzyme linked immunosorbent assay |
carotid artery |
0 |
|
0 |
|
immunoreactive leptin kit; Morinaga Institute of Biological Science, Yokohama, Japan |
|
|
65740 |
248 |
SS/Jr |
urine albumin excretion rate |
controlled sodium content diet (0.2 %) |
Poyan Mehr A, et al., Physiol Genomics 2003 Aug 15;14(3):209-16. |
urine albumin amount |
not specified |
196 days
| 12 |
|
148.47 |
mg/d |
|
|
enzyme linked immunosorbent assay |
urine |
0.0 |
|
0 |
|
rat albumin ELISA |
|
|
13283 |
335 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
serum insulin level |
fasting (between 6 and 7 hours) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood insulin amount |
male |
185 days
| 10 |
|
0.03 |
mg/dl |
0.0 |
0.01 |
enzyme linked immunosorbent assay |
tail vein |
0.0 |
|
0 |
|
|
|
|
67645 |
85 |
F344/NSlc |
serum adiponectin level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood adiponectin amount |
male |
211 days
| 7 |
|
3.28 |
ng/ml |
0.3 |
0.79 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) |
|
|
67479 |
311 |
F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj |
serum adiponectin level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood adiponectin amount |
male |
211 days
| 11 |
|
2.75 |
ng/ml |
0.2 |
0.66 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) |
|
|
67482 |
311 |
F344/NSlc |
serum leptin level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood leptin amount |
male |
211 days
| 7 |
|
5.46 |
ng/ml |
1.06 |
2.8 |
enzyme linked immunosorbent assay |
|
0.0 |
oral glucose |
7 |
days |
ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) |
|
|
67483 |
311 |
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj |
serum leptin level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood leptin amount |
male |
211 days
| 7 |
|
2.8 |
ng/ml |
0.54 |
1.43 |
enzyme linked immunosorbent assay |
|
0.0 |
oral glucose |
7 |
days |
ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) |
|
|
67484 |
311 |
MWF/FubRkb |
urine albumin excretion rate |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
urine albumin amount |
male |
168 days
| 0 |
|
162.6 |
mg/d |
15.9 |
|
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68184 |
309 |
MWF/FubRkb |
urine albumin excretion rate |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
urine albumin amount |
female |
224 days
| 0 |
|
18.6 |
mg/d |
3.0 |
|
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68186 |
309 |
BN/Crl |
plasma insulin level |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
blood insulin amount |
female |
60 days
| 6 |
|
6.06 |
mU/l |
0.81 |
1.97 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68777 |
1012 |
F344/DuCrlCrlj |
serum leptin level |
fasting (for 16 hours) |
Yamasaki Y, et al., Clin Exp Pharmacol Physiol 2000 Nov;27(11):881-6. |
blood leptin amount |
male |
112 days
| 15 |
|
16.32 |
ng/ml |
0.93 |
3.6 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68971 |
1035 |
BN/SsN |
calculated serum anti-rat type 2 collagen autoantibody titer |
Freund's incomplete adjuvant (50 %) and type II collagen (2 mg/kg) |
Furuya T, et al., Hum Mol Genet 2000 Sep 22;9(15):2241-50 |
blood autoantibody amount |
female |
66 days-126 days |
7 |
|
1.9 |
null |
0.68 |
1.8 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
titer |
|
69928 |
1241 |
DA/BklArbNsi |
inflammatory exudate tumor necrosis factor level |
room temperature (14 ml) (for 3 days) then room temperature (10 ml) (for 3 days) then carrageenan (1 ml) (for 6 hours) |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
tumor necrosis factor amount |
female |
56 days-98 days |
9 |
|
2071.0 |
pg/ml |
271.0 |
813.0 |
enzyme linked immunosorbent assay |
subcutaneous interscapular cavity |
0.0 |
|
0 |
|
hemocytometer |
inflammatory air pouch exudate Tnf level |
|
68399 |
332 |
MWF/FubRkb |
urine albumin excretion rate |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
urine albumin amount |
female |
168 days
| 0 |
|
24.0 |
mg/d |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
69947 |
309 |
BB.SHR-(Gnal-D18Mit9)/K |
serum insulin level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
blood insulin amount |
both |
84 days
| 25 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
opthalmic venous plexus |
0.0 |
|
0 |
|
|
ng/ml is unit |
|
70100 |
324 |
SS/JrHsdMcwi |
urine podocalyxin excretion rate |
physical restraint (20-30 min/d) (for 4 days) |
McPherson KC, et al., Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F793-F804. doi: 10.1152/ajprenal.00590.2015. Epub 2016 Jul 27. |
urine podocalyxin amount |
male |
126 days
| 6 |
|
47.0 |
ug/d |
7.0 |
17.15 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
100085 |
2418 |
GK |
plasma insulin level |
bilateral ovariectomy (for 24 days) |
Apaijai N, et al., Biosci Rep. 2017 Oct 17;37(5). pii: BSR20170886. doi: 10.1042/BSR20170886. Print 2017 Oct 31. |
blood insulin amount |
female |
87 days
| 6 |
|
23.4 |
mU/l |
5.2 |
12.74 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
103764 |
2782 |
Jcl:WI |
serum insulin level |
control condition |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood insulin amount |
male |
52 days
| 6 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
103936 |
2884 |
Jcl:WI |
liver triglyceride level |
control condition |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
liver triglyceride amount |
male |
52 days
| 6 |
|
10.04 |
mg/g |
1.09 |
2.67 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
103970 |
2884 |
GK/Jcl |
liver triglyceride level |
controlled hesperidin content diet (1 %) (for 28 days) |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
liver triglyceride amount |
male |
52 days
| 6 |
|
11.37 |
mg/g |
1.3 |
3.18 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
103972 |
2884 |
SS-Leprem2Mcwi |
plasma leptin level |
control condition |
McPherson KC, et al., Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F793-F804. doi: 10.1152/ajprenal.00590.2015. Epub 2016 Jul 27. |
blood leptin amount |
male |
42 days
| 5 |
|
84.7 |
ng/ml |
4.5 |
10.06 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
100072 |
2418 |
SS-Leprem2Mcwi |
plasma total cholesterol level |
control condition |
McPherson KC, et al., Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F793-F804. doi: 10.1152/ajprenal.00590.2015. Epub 2016 Jul 27. |
blood cholesterol amount |
male |
42 days
| 7 |
|
178.0 |
mg/dl |
15.0 |
39.69 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
100074 |
2418 |
SS-Leprem2Mcwi |
plasma triglyceride level |
control condition |
McPherson KC, et al., Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F793-F804. doi: 10.1152/ajprenal.00590.2015. Epub 2016 Jul 27. |
blood triglyceride amount |
male |
42 days
| 7 |
|
2.03 |
mmol/l |
0.38 |
1.02 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
100076 |
2418 |
Crl:WI |
serum insulin level |
control condition |
Korkmaz-Ic�z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. |
blood insulin amount |
male |
112 days
| 10 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
102942 |
2783 |
SD-Apoeem1Sage |
serum oxidized LDL level |
control condition |
Ekuni D, et al., Lipids Health Dis. 2014 Sep 5;13:144. doi: 10.1186/1476-511X-13-144. |
serum oxidized LDL amount |
male |
56 days
| 7 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
104505 |
2968 |
SD |
serum total immunoglobulin E level |
vehicle control condition then acetic acid (for 0 hours) then physical restraint in tube type rodent restrainer (for 2 hours) then fasting (for 1 days) |
Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. |
blood immunoglobulin E amount |
not specified |
0 days
| 4 |
|
0.2 |
ug/l |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
error not defined |
|
105407 |
3015 |
SD-Lepem1Sage-/- |
plasma insulin level |
fasting (for 4 hours) |
D'souza AM, et al., Endocrinology. 2014 Apr;155(4):1268-79. doi: 10.1210/en.2013-1523. Epub 2014 Jan 27. |
blood insulin amount |
male |
42 days
| 6 |
|
327.08 |
mU/l |
47.32 |
115.91 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
104455 |
2949 |
SD-Lepem1Sage+/+ |
plasma insulin level |
fasting (for 4 hours) |
D'souza AM, et al., Endocrinology. 2014 Apr;155(4):1268-79. doi: 10.1210/en.2013-1523. Epub 2014 Jan 27. |
blood insulin amount |
female |
42 days
| 6 |
|
18.2 |
mU/l |
0.52 |
1.27 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
104456 |
2949 |
SS/JrHsdMcwi |
plasma interleukin-6 level |
control condition (for 84 days) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
blood interleukin-6 amount |
male |
84 days
| 6 |
|
17.0 |
pg/ml |
2.0 |
4.9 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
105858 |
3023 |
SS-Adora2bem2Mcwi |
plasma interleukin-6 level |
control condition (for 84 days) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
blood interleukin-6 amount |
male |
84 days
| 6 |
|
28.0 |
pg/ml |
3.0 |
7.35 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
105859 |
3023 |
SD |
serum total immunoglobulin E level |
acetic acid (for 0 hours) then physical restraint in tube type rodent restrainer (for 2 hours) then fasting (for 1 days) |
Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. |
blood immunoglobulin E amount |
not specified |
0 days
| 12 |
|
0.28 |
ug/l |
0.01 |
0.05 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
error not defined |
|
105409 |
3015 |
BUF/SimRijHsd |
number of individuals in a study population displaying Pasteurellaceae infection at a point in time |
Haemophilus |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
not specified |
70 days-84 days |
8 |
|
4.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108613 |
3072 |
Crl:WI |
urine albumin excretion rate |
vehicle control condition (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
urine albumin amount |
male |
114 days
| 10 |
|
0.17 |
mg/d |
0.01 |
0.03 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
109403 |
3140 |
BN/RijHsd |
number of individuals in a study population displaying Pasteurellaceae infection at a point in time |
Haemophilus |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
not specified |
70 days-84 days |
8 |
|
8.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108612 |
3072 |
WKY/NIcoCrlf |
number of individuals in a study population displaying Haemophilus H35 infection at a point in time |
housing in trios (for 42 days) and housing with Haemophilus H35-infected subject (for 42 days) |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
female |
70 days-84 days |
6 |
|
6.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
pathogen |
42 |
days |
|
|
|
108625 |
3072 |
SHR/FubRkb |
urine albumin excretion rate |
controlled NG-nitroarginine methyl ester content drinking water (5 mg/kg/d) (for 42 days) |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
urine albumin amount |
male |
84 days
| 10 |
|
0.8 |
mg/d |
0.2 |
0.63 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108129 |
3116 |
BN/RijHsd |
number of individuals in a study population displaying Pasteurella pneumotropica infection at a point in time |
Haemophilus |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
not specified |
70 days-84 days |
8 |
|
8.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108607 |
3072 |
WAG/RijHfr |
number of individuals in a study population displaying Pasteurellaceae infection at a point in time |
Haemophilus |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
not specified |
70 days-84 days |
8 |
|
6.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108615 |
3072 |
LEW/Crl |
number of individuals in a study population displaying Haemophilus H21 infection at a point in time |
housing in trios (for 42 days) and housing with Haemophilus H21-infected subject (for 42 days) |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
female |
70 days-84 days |
6 |
|
3.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
pathogen |
42 |
days |
|
|
|
108619 |
3072 |
F344/IcoCrlf |
number of individuals in a study population displaying Haemophilus H35 infection at a point in time |
housing in trios (for 42 days) and housing with Haemophilus H35-infected subject (for 42 days) |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
female |
70 days-84 days |
6 |
|
4.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
pathogen |
42 |
days |
|
|
|
108623 |
3072 |
BN/OrlIcoCrlf |
number of individuals in a study population displaying Pasteurellaceae infection at a point in time |
housing in trios (for 42 days) and housing with Pasteurellaceae-infected subject (for 42 days) |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
female |
70 days-84 days |
6 |
|
6.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
pathogen |
42 |
days |
|
|
|
108632 |
3072 |
SHR/FubRkb |
urine albumin excretion rate |
sham surgical control condition (for 42 days) |
Schulz A, etal., Physiol Genomics. 2012 Jan 18;44(1):110-6. Epub 2011 Nov 22. |
urine albumin amount |
male |
84 days
| 9 |
|
0.4 |
mg/d |
0.1 |
0.3 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
109562 |
3148 |
GK/Jpe |
urine 8-hydroxy-2'-deoxyguanosine level |
controlled cocoa butter content diet (7.5 %) (for 90 days) and controlled cholesterol content diet (1.25 %) (for 90 days) and lipoic acid (50 mg/kg) (for 90 days) then fasting (for 15 hours) |
Sena CM, etal., Int J Mol Sci. 2018 Sep 11;19(9). pii: ijms19092706. doi: 10.3390/ijms19092706. |
urine molecular composition trait |
male |
540 days
| 7 |
|
5.63 |
ng/d |
0.36 |
0.95 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
110930 |
3193 |
BUF/SimRijHsd |
number of individuals in a study population displaying Haemophilus H21 infection at a point in time |
Haemophilus |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
not specified |
70 days-84 days |
8 |
|
2.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
107795 |
3072 |
MWF/FubRkb |
urine albumin excretion rate |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
urine albumin amount |
male |
30 days
| 5 |
|
0.14 |
mg/d |
0.05 |
0.11 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
109715 |
3152 |
MWF/FubRkb |
urine albumin excretion rate |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
urine albumin amount |
female |
30 days
| 5 |
|
0.11 |
mg/d |
0.02 |
0.04 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
109716 |
3152 |
Jcl:WI |
serum insulin level |
fasting |
Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5. |
blood insulin amount |
male |
154 days
| 7 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
110213 |
3167 |
Jcl:WI |
serum insulin level |
vildagliptin (30 mg/kg/d) (for 92 days) then fasting then glucose solution (2 g/kg) (for 0.5 hours) |
Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5. |
blood insulin amount |
male |
140 days
| 7 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
glucose |
30 |
min |
|
|
|
110218 |
3167 |
SHR/FubRkb |
urine albumin excretion rate |
control condition |
Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. |
urine albumin amount |
male |
84 days
| 10 |
|
1.1 |
mg/d |
0.2 |
0.63 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
109285 |
3141 |
MWF/FubRkb |
urine albumin excretion rate |
sham surgical control condition |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
urine albumin amount |
male |
168 days
| 10 |
|
108.7 |
mg/d |
12.3 |
38.9 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108124 |
3116 |
SHR-Chr 6MWF/Rkb |
urine albumin excretion rate |
control condition |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
urine albumin amount |
male |
84 days
| 10 |
|
0.2 |
mg/d |
0.02 |
0.06 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108142 |
3116 |
HsdCpb:WU |
urine albumin excretion rate |
sham surgical control condition (for 84 days) |
Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. |
urine albumin amount |
not specified |
84 days
| 15 |
|
0.2 |
mg/d |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
109658 |
3149 |
Hsd:SD |
plasma leptin level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood leptin amount |
male |
448 days
| 9 |
|
9.83 |
ng/ml |
0.68 |
2.04 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
138314 |
3201 |
SD-Ldlrem1Sage |
plasma leptin level |
controlled fat content diet (42 %) (for 364 days) |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood leptin amount |
male |
448 days
| 16 |
|
65.59 |
ng/ml |
7.52 |
30.08 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
138317 |
3201 |
Hsd:SD |
plasma adiponectin level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood adiponectin amount |
male |
448 days
| 9 |
|
82.96 |
ug/ml |
4.73 |
14.19 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
138318 |
3201 |
BRAT-Avpdi/BluHsd |
kidney papilla hyaluronic acid level |
desmopressin (100 ug/kg) (for 2 days) |
Ivanova LN, et al., Exp Physiol. 2013 Nov;98(11):1608-19. doi: 10.1113/expphysiol.2013.073163. Epub 2013 Aug 16. |
kidney molecular composition trait |
not specified |
0 days
| 5 |
|
1.9 |
mg/g |
0.1 |
0.22 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
107220 |
3078 |
MWF-Chr 8SHR/Rkb |
urine albumin excretion rate |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
urine albumin amount |
male |
126 days-224 days |
10 |
|
20.0 |
mg/d |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108967 |
3133 |
SHR/FubRkb |
urine albumin excretion rate |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
urine albumin amount |
female |
56 days
| 10 |
|
0.1 |
mg/d |
0.01 |
0.03 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108970 |
3133 |
BB.SHR-(D4Got41-Tacr1)/K |
serum insulin level |
control condition |
Kloting N, et al., Obes Res 2005 Mar;13(3):589-95. |
blood insulin amount |
male |
224 days
| 20 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
ng/ml |
|
11938 |
227 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
serum insulin level |
fasting (between 6 and 7 hours) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood insulin amount |
male |
185 days
| 10 |
|
0.04 |
mg/dl |
0.0 |
0.01 |
enzyme linked immunosorbent assay |
tail vein |
0.0 |
|
0 |
|
|
|
|
67646 |
85 |
F344/NHsd |
inflammatory exudate tumor necrosis factor level |
room temperature (14 ml) (for 3 days) then room temperature (10 ml) (for 3 days) then carrageenan (1 ml) (for 6 hours) |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
tumor necrosis factor amount |
female |
56 days-98 days |
9 |
|
809.0 |
pg/ml |
143.0 |
429.0 |
enzyme linked immunosorbent assay |
subcutaneous interscapular cavity |
0.0 |
|
0 |
|
hemocytometer |
inflammatory air pouch exudate Tnf level |
|
68400 |
332 |
MWF/FubRkb |
urine albumin excretion rate |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
urine albumin amount |
female |
56 days
| 0 |
|
5.2 |
mg/d |
0.8 |
|
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
69944 |
309 |
BN/Crl |
plasma insulin level |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
blood insulin amount |
male |
60 days
| 6 |
|
6.4 |
mU/l |
1.12 |
2.74 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68776 |
1012 |
OLETF/Got |
serum leptin level |
fasting (for 16 hours) |
Yamasaki Y, et al., Clin Exp Pharmacol Physiol 2000 Nov;27(11):881-6. |
blood leptin amount |
male |
112 days
| 25 |
|
32.48 |
ng/ml |
1.64 |
8.2 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68970 |
1035 |
F344.GK-(D1Got250-D1Rat90)/Swe |
pancreas insulin level to pancreas total protein ratio |
control condition |
Granhall C, et al., Diabetes. 2006 Dec;55(12):3494-500. |
pancreas insulin amount |
male |
60 days
| 6 |
|
299.0 |
ng/mg |
20.0 |
48.99 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68147 |
333 |
BN/SsN |
calculated serum anti-rat type 2 collagen autoantibody titer |
Freund's incomplete adjuvant (50 %) and type II collagen (2 mg/kg) |
Furuya T, et al., Hum Mol Genet 2000 Sep 22;9(15):2241-50 |
blood autoantibody amount |
male |
66 days-126 days |
13 |
|
1.3 |
null |
0.28 |
1.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
titer |
|
69927 |
1241 |
Crlj:WI |
plasma insulin level |
fasting (for 17 hours) |
Mine T, etal., Biol Pharm Bull. 2002 Nov;25(11):1412-6. doi: 10.1248/bpb.25.1412. |
blood insulin amount |
male |
224 days-238 days |
5 |
|
62.4 |
mU/l |
10.4 |
23.26 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
enzyme immunoassay (MMO:0000713) |
|
|
108088 |
3070 |
GK/KyoSwe |
change in blood insulin level |
fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) |
Galli J, et al., NatGenet 1996 Jan;12(1):31-7. |
blood insulin amount |
not specified |
65 days
| 4 |
|
4.0 |
mU/l |
2.9 |
5.8 |
enzyme linked immunosorbent assay |
|
|
glucose injection |
30 |
min |
|
change from baseline |
|
11390 |
82 |
F344/DuCrl |
blood insulin level |
fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) |
Galli J, et al., NatGenet 1996 Jan;12(1):31-7. |
blood insulin amount |
not specified |
65 days
| 3 |
|
23.6 |
mU/l |
4.9 |
8.49 |
enzyme linked immunosorbent assay |
|
|
glucose injection |
0 |
min |
|
|
|
11398 |
82 |
F344/DuCrl |
change in blood insulin level |
fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) |
Galli J, et al., NatGenet 1996 Jan;12(1):31-7. |
blood insulin amount |
not specified |
65 days
| 3 |
|
-3.2 |
mU/l |
6.1 |
10.57 |
enzyme linked immunosorbent assay |
|
|
glucose injection |
30 |
min |
|
|
|
11399 |
82 |
SHR/Fub |
urine albumin excretion rate |
controlled sodium content diet (0.2 %) |
Poyan Mehr A, et al., Physiol Genomics 2003 Aug 15;14(3):209-16. |
urine albumin amount |
not specified |
28 days
| 11 |
|
0.03 |
mg/d |
|
|
enzyme linked immunosorbent assay |
urine |
0.0 |
|
0 |
|
rat albumin ELISA |
|
|
13282 |
335 |
BB.WOKW-(D4Got41-Fabp1)/K |
serum insulin level |
control condition |
Kloting N, et al., Obes Res 2005 Mar;13(3):589-95. |
blood insulin amount |
male |
224 days
| 16 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
ng/ml |
|
11942 |
227 |
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj |
serum adiponectin level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood adiponectin amount |
male |
211 days
| 7 |
|
3.03 |
ng/ml |
0.23 |
0.61 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) |
|
|
67480 |
311 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
serum adiponectin level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood adiponectin amount |
male |
211 days
| 11 |
|
3.02 |
ng/ml |
0.15 |
0.5 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) |
|
|
67481 |
311 |
SHR/FubRkb |
urine albumin excretion rate |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
urine albumin amount |
not specified |
168 days
| 10 |
|
2.3 |
mg/d |
1.1 |
3.48 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
65275 |
117 |
MWF/FubRkb |
urine albumin excretion rate |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
urine albumin amount |
not specified |
224 days
| 10 |
|
354.6 |
mg/d |
112.9 |
357.02 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
65419 |
117 |
BN/Crl |
plasma insulin-like growth factor 1 level |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
blood insulin-like growth factor amount |
male |
60 days
| 6 |
|
846.0 |
ng/ml |
288.0 |
705.45 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68784 |
1012 |
GK/Ox |
plasma insulin-like growth factor 1 level |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
blood insulin-like growth factor amount |
male |
60 days
| 6 |
|
1180.0 |
ng/ml |
162.0 |
396.82 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68786 |
1012 |
BN/Crl |
plasma prolactin level |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
blood prolactin amount |
male |
60 days
| 6 |
|
36.0 |
ng/ml |
5.0 |
12.25 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68792 |
1012 |
COP.DA-(D3Rat233-D3Mgh14)/Mco |
plasma insulin level |
fasting (for 16 hours) |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
blood insulin amount |
not specified |
105 days
| 10 |
|
26.52 |
mU/l |
8.06 |
25.49 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68574 |
933 |
BBDR/Rhw |
calculated serum anti-rat type 2 collagen autoantibody titer |
Freund's incomplete adjuvant (50 %) and type II collagen (2 mg/kg) |
Furuya T, et al., Hum Mol Genet 2000 Sep 22;9(15):2241-50 |
blood autoantibody amount |
female |
66 days-126 days |
13 |
|
31.7 |
null |
1.75 |
6.3 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
titer |
|
69926 |
1241 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
pancreas insulin level to pancreas total protein ratio |
control condition |
Granhall C, et al., Diabetes. 2006 Dec;55(12):3494-500. |
pancreas insulin amount |
male |
60 days
| 6 |
|
231.0 |
ng/mg |
18.0 |
44.09 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68145 |
333 |
F344.GK-(D1Mgh14-D1Rat90)/Swe |
pancreas insulin level to pancreas total protein ratio |
control condition |
Granhall C, et al., Diabetes. 2006 Dec;55(12):3494-500. |
pancreas insulin amount |
male |
60 days
| 6 |
|
239.0 |
ng/mg |
33.0 |
80.83 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68148 |
333 |
F344.GK-(D1Swe4-D1Rat85)/Swe |
pancreas insulin level to pancreas total protein ratio |
control condition |
Granhall C, et al., Diabetes. 2006 Dec;55(12):3494-500. |
pancreas insulin amount |
male |
60 days
| 6 |
|
196.0 |
ng/mg |
25.0 |
61.24 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68150 |
333 |
DA/BklArbNsi |
inflammatory exudate lipoxin A4 level |
room temperature (14 ml) (for 3 days) then room temperature (10 ml) (for 3 days) then carrageenan (1 ml) (for 6 hours) |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
eicosanoid amount |
female |
56 days-98 days |
9 |
median |
26.0 |
pg/ml |
|
|
enzyme linked immunosorbent assay |
subcutaneous interscapular cavity |
0.0 |
|
0 |
|
|
inflammatory exudate LXA4 measurement |
|
68408 |
332 |
Crl:WI(Han) |
plasma insulin level |
bilateral ovariectomy (for 24 days) |
Apaijai N, et al., Biosci Rep. 2017 Oct 17;37(5). pii: BSR20170886. doi: 10.1042/BSR20170886. Print 2017 Oct 31. |
blood insulin amount |
female |
87 days
| 6 |
|
213.2 |
mU/l |
46.8 |
114.64 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
103762 |
2782 |
Crl:WI(Han) |
plasma estradiol level |
sham surgical control condition (for 24 days) |
Apaijai N, et al., Biosci Rep. 2017 Oct 17;37(5). pii: BSR20170886. doi: 10.1042/BSR20170886. Print 2017 Oct 31. |
blood estradiol amount |
female |
87 days
| 6 |
|
48.6 |
pg/ml |
9.2 |
22.54 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
103773 |
2782 |
GK |
plasma estradiol level |
bilateral ovariectomy (for 24 days) |
Apaijai N, et al., Biosci Rep. 2017 Oct 17;37(5). pii: BSR20170886. doi: 10.1042/BSR20170886. Print 2017 Oct 31. |
blood estradiol amount |
female |
87 days
| 6 |
|
30.1 |
pg/ml |
2.1 |
5.14 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
103776 |
2782 |
SS/JrHsdMcwi |
urine podocalyxin excretion rate |
physical restraint (20-30 min/d) (for 4 days) |
McPherson KC, et al., Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F793-F804. doi: 10.1152/ajprenal.00590.2015. Epub 2016 Jul 27. |
urine podocalyxin amount |
male |
42 days
| 6 |
|
17.0 |
ug/d |
2.0 |
4.9 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
100083 |
2418 |
GK/Jcl |
serum adiponectin level |
controlled hesperidin content diet (1 %) (for 28 days) |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood adiponectin amount |
male |
52 days
| 6 |
|
18.26 |
ng/ml |
2.14 |
5.24 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
103942 |
2884 |
GK/Jcl |
serum adiponectin level |
controlled cyclodextrin (CD)-clathrated hesperetin content diet (4.6 %) (for 28 days) |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood adiponectin amount |
male |
52 days
| 6 |
|
22.3 |
ng/ml |
1.65 |
4.04 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
103943 |
2884 |
SD |
heart left ventricle interstitial norepinephrine level during a period of time |
artificial aortocaval fistula (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle interstitial norepinephrine amount |
male |
98 days
| 9 |
|
6.8 |
pg/hr |
0.8 |
2.4 |
enzyme linked immunosorbent assay |
|
0.0 |
ACF |
28 |
days |
|
heart left ventricle interstitial bradykinin level during a period of time |
|
99268 |
2278 |
SD |
heart left ventricle interstitial norepinephrine level during a period of time |
sham surgical control condition (for 105 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle interstitial norepinephrine amount |
male |
175 days
| 8 |
|
5.9 |
pg/hr |
0.4 |
1.13 |
enzyme linked immunosorbent assay |
|
0.0 |
sham ACF |
105 |
days |
|
heart left ventricle interstitial bradykinin level during a period of time |
|
99269 |
2278 |
SD |
heart left ventricle interstitial epinephrine level during a period of time |
artificial aortocaval fistula (for 105 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle interstitial epinephrine amount |
male |
175 days
| 10 |
|
8.6 |
pg/hr |
1.1 |
3.48 |
enzyme linked immunosorbent assay |
|
0.0 |
ACF |
105 |
days |
|
heart left ventricle interstitial epinephrine level during a period of time |
|
99274 |
2278 |
SD |
plasma norepinephrine level |
artificial aortocaval fistula (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
blood norepinephrine amount |
male |
98 days
| 9 |
|
89.0 |
pg/ml |
8.0 |
24.0 |
enzyme linked immunosorbent assay |
|
0.0 |
ACF |
28 |
days |
|
|
|
99284 |
2278 |
SD |
plasma norepinephrine level |
artificial aortocaval fistula (for 105 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
blood norepinephrine amount |
male |
175 days
| 10 |
|
159.0 |
pg/ml |
17.0 |
53.76 |
enzyme linked immunosorbent assay |
|
0.0 |
ACF |
105 |
days |
|
|
|
99286 |
2278 |
SD-Apoeem1Sage |
serum C-reactive protein level |
removal of maxillary molar crown (for 56 days) |
Ekuni D, et al., Lipids Health Dis. 2014 Sep 5;13:144. doi: 10.1186/1476-511X-13-144. |
C-reactive protein amount |
male |
56 days
| 7 |
|
1.0 |
mg/l |
0.08 |
0.2 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
104510 |
2968 |
SD |
serum immunoglobulin E level |
control condition |
Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. |
blood immunoglobulin E amount |
not specified |
0 days
| 8 |
|
0.1 |
ug/l |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
error not defined |
|
105406 |
3015 |
SD |
serum total immunoglobulin E level |
acetic acid (for 0 hours) then physical restraint in tube type rodent restrainer (for 2 hours) then fasting (for 1 days) |
Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. |
blood immunoglobulin E amount |
not specified |
0 days
| 12 |
|
0.1 |
ug/l |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
error not defined |
|
105408 |
3015 |
SD |
serum interleukin-4 level |
control condition |
Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. |
blood interleukin-4 amount |
not specified |
0 days
| 8 |
|
0.04 |
ug/l |
0.0 |
0.01 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
error not defined |
|
105410 |
3015 |
SD |
serum interleukin-4 level |
acetic acid (for 0 hours) then physical restraint in tube type rodent restrainer (for 2 hours) then fasting (for 1 days) |
Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. |
blood interleukin-4 amount |
not specified |
0 days
| 12 |
|
0.15 |
ug/l |
0.01 |
0.02 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
error not defined |
|
105413 |
3015 |
SD |
serum interleukin-9 level |
vehicle control condition then acetic acid (for 0 hours) then physical restraint in tube type rodent restrainer (for 2 hours) then fasting (for 1 days) |
Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. |
blood interleukin-9 amount |
not specified |
0 days
| 4 |
|
0.1 |
ug/l |
0.01 |
0.01 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
error not defined |
|
105415 |
3015 |
SD |
intestine trypsin level |
control condition |
Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. |
intestine trypsin amount |
not specified |
0 days
| 8 |
|
0.08 |
ug/l |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
error not defined |
|
105418 |
3015 |
Crl:WI |
urine albumin excretion rate |
finerenone (10 null) (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
urine albumin amount |
male |
114 days
| 10 |
|
0.22 |
mg/d |
0.04 |
0.13 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
109404 |
3140 |
GK |
plasma leptin level |
running (3.91 km/d) (for 42 days) |
Kupai K, et al., Diabetol Metab Syndr. 2015 Oct 6;7:85. doi: 10.1186/s13098-015-0080-x. eCollection 2015. |
blood leptin amount |
male |
0 days
| 20 |
|
0.17 |
ng/ml |
0.0 |
0.02 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
109900 |
3160 |
GK/CskCrlj |
plasma insulin level |
fasting (for 17 hours) |
Mine T, etal., Biol Pharm Bull. 2002 Nov;25(11):1412-6. doi: 10.1248/bpb.25.1412. |
blood insulin amount |
male |
224 days-238 days |
10 |
|
28.6 |
mU/l |
2.6 |
8.22 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
enzyme immunoassay (MMO:0000713) |
|
|
106892 |
3070 |
RP/AEurRijHsd |
number of individuals in a study population displaying Pasteurella pneumotropica infection at a point in time |
Haemophilus |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
not specified |
70 days-84 days |
8 |
|
0.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108606 |
3072 |
WKY/NIcoCrlf |
number of individuals in a study population displaying Pasteurellaceae infection at a point in time |
housing in trios (for 42 days) and housing with Pasteurellaceae-infected subject (for 42 days) |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
female |
70 days-84 days |
6 |
|
6.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
pathogen |
42 |
days |
|
|
|
108635 |
3072 |
BN/RijHsd |
number of individuals in a study population displaying Haemophilus H35 infection at a point in time |
Haemophilus |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
not specified |
70 days-84 days |
8 |
|
7.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108602 |
3072 |
LEW/HanHfr |
number of individuals in a study population displaying Pasteurellaceae infection at a point in time |
Haemophilus |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
not specified |
70 days-84 days |
8 |
|
5.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108614 |
3072 |
BN/OrlIcoCrlf |
number of individuals in a study population displaying Haemophilus H35 infection at a point in time |
housing in trios (for 42 days) and housing with Haemophilus H35-infected subject (for 42 days) |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
female |
70 days-84 days |
6 |
|
5.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
pathogen |
42 |
days |
|
|
|
108622 |
3072 |
BDIX/Han |
number of individuals in a study population displaying Pasteurella pneumotropica infection at a point in time |
housing in trios (for 42 days) and housing with Pasteurella pneumotropica-infected subject (for 42 days) |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
female |
70 days-84 days |
6 |
|
4.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
pathogen |
42 |
days |
|
|
|
108626 |
3072 |
SHR-Chr 6MWF/Rkb |
urine albumin excretion rate |
sham surgical control condition |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
urine albumin amount |
male |
168 days
| 10 |
|
0.5 |
mg/d |
0.2 |
0.63 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108127 |
3116 |
GK/Jpe |
urine 8-hydroxy-2'-deoxyguanosine level |
fasting (for 15 hours) |
Sena CM, etal., Int J Mol Sci. 2018 Sep 11;19(9). pii: ijms19092706. doi: 10.3390/ijms19092706. |
urine molecular composition trait |
male |
540 days
| 7 |
|
306.57 |
ng/d |
23.76 |
62.86 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
110927 |
3193 |
WKY/NMolTac |
serum insulin level |
fasting (for 6 hours) |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood insulin amount |
female |
240 days
| 9 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
fasting insulin, non fasting insulin |
106927 |
3071 |
WKY/NMolTac |
serum insulin level |
fasting (for 6 hours) |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood insulin amount |
female |
420 days
| 9 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
fasting insulin, non fasting insulin |
106928 |
3071 |
RP/AEurRijHsd |
number of individuals in a study population displaying Haemophilus H35 infection at a point in time |
Haemophilus |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
not specified |
70 days-84 days |
8 |
|
3.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108601 |
3072 |
RP/AEurRijHsd |
number of individuals in a study population displaying Pasteurellaceae infection at a point in time |
Haemophilus |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
not specified |
70 days-84 days |
8 |
|
1.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108611 |
3072 |
F344/IcoCrlf |
number of individuals in a study population displaying Pasteurellaceae infection at a point in time |
housing in trios (for 42 days) and housing with Pasteurellaceae-infected subject (for 42 days) |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
female |
70 days-84 days |
6 |
|
5.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
pathogen |
42 |
days |
|
|
|
108633 |
3072 |
SHR-Chr 8MWF/Rkb |
urine albumin excretion rate |
sham surgical control condition (for 126 days) |
Schulz A, etal., Physiol Genomics. 2012 Jan 18;44(1):110-6. Epub 2011 Nov 22. |
urine albumin amount |
male |
168 days
| 9 |
|
10.8 |
mg/d |
2.1 |
6.3 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
109563 |
3148 |
GK/Jpe |
urine 8-hydroxy-2'-deoxyguanosine level |
controlled cocoa butter content diet (7.5 %) (for 90 days) and controlled cholesterol content diet (1.25 %) (for 90 days) then fasting (for 15 hours) |
Sena CM, etal., Int J Mol Sci. 2018 Sep 11;19(9). pii: ijms19092706. doi: 10.3390/ijms19092706. |
urine molecular composition trait |
male |
540 days
| 7 |
|
415.8 |
ng/d |
74.29 |
196.55 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
110928 |
3193 |
RP/AEurRijHsd |
number of individuals in a study population displaying Haemophilus H21 infection at a point in time |
Haemophilus |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
not specified |
70 days-84 days |
8 |
|
0.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
107793 |
3072 |
BN/RijHsd |
number of individuals in a study population displaying Haemophilus H21 infection at a point in time |
Haemophilus |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
not specified |
70 days-84 days |
8 |
|
8.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
107794 |
3072 |
Hsd:WI |
urine albumin excretion rate |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
urine albumin amount |
not specified |
100 days
| 0 |
|
0.2 |
mg/d |
0.02 |
|
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108107 |
3115 |
WAG/Nov |
kidney cortex hyaluronic acid level |
sodium chloride solution (1 ml) (for 2 days) |
Ivanova LN, et al., Exp Physiol. 2013 Nov;98(11):1608-19. doi: 10.1113/expphysiol.2013.073163. Epub 2013 Aug 16. |
kidney molecular composition trait |
not specified |
0 days
| 4 |
|
0.71 |
mg/g |
0.05 |
0.1 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
107211 |
3078 |
Jcl:WI |
serum glucagon-like peptide 1 level |
fasting |
Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5. |
blood glucagon-like peptide amount |
male |
154 days
| 7 |
|
34.0 |
pg/ml |
5.0 |
13.23 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
110221 |
3167 |
GK/Jcl |
serum glucagon-like peptide 1 level |
vildagliptin (30 mg/kg/d) (for 106 days) then fasting |
Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5. |
blood glucagon-like peptide amount |
male |
154 days
| 7 |
|
43.1 |
pg/ml |
4.95 |
13.1 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
110224 |
3167 |
SHR-Chr 6MWF/Rkb |
urine albumin excretion rate |
controlled NG-nitroarginine methyl ester content drinking water (5 mg/kg/d) (for 42 days) |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
urine albumin amount |
male |
84 days
| 8 |
|
8.0 |
mg/d |
7.3 |
20.65 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108143 |
3116 |
MWF/FubRkb |
urine albumin excretion rate |
sham surgical control condition (for 84 days) |
Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. |
urine albumin amount |
not specified |
84 days
| 15 |
|
58.1 |
mg/d |
5.8 |
22.46 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
109659 |
3149 |
SD-Ldlrem1Sage |
blood interleukin-4 level |
controlled fat content diet (42 %) |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood interleukin-4 amount |
male |
448 days
| 16 |
|
25.0 |
pg/ml |
3.0 |
12.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
138362 |
3201 |
SD-Ldlrem1Sage |
plasma plasminogen activator inhibitor 1 level |
controlled fat content diet (42 %) (for 364 days) |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood plasminogen activator inhibitor 1 amount |
male |
448 days
| 16 |
|
14.15 |
ng/ml |
1.27 |
5.08 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
138309 |
3201 |
BB.SHR-(D6Rat184-D6Rat3)/K |
serum insulin level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
blood insulin amount |
both |
84 days
| 46 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
opthalmic venous plexus |
0.0 |
|
0 |
|
|
ng/ml is unit |
|
12981 |
324 |
GK/Ox |
plasma corticosterone level |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
blood corticosterone amount |
male |
60 days
| 6 |
|
523.0 |
ng/ml |
86.0 |
210.66 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68790 |
1012 |
BN/Crl |
plasma prolactin level |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
blood prolactin amount |
female |
60 days
| 6 |
|
113.0 |
ng/ml |
17.0 |
41.64 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68793 |
1012 |
GK/Ox |
plasma insulin level |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
blood insulin amount |
female |
60 days
| 6 |
|
9.1 |
mU/l |
1.38 |
3.38 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68779 |
1012 |
COP.DA-(D16Rat12-D16Rat90)/Mco |
plasma insulin level |
fasting (for 16 hours) |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
blood insulin amount |
not specified |
105 days
| 10 |
|
32.5 |
mU/l |
7.54 |
23.84 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68573 |
933 |
F344.GK-(D1Rat83-D1Rat376)/Swe |
pancreas insulin level to pancreas total protein ratio |
control condition |
Granhall C, et al., Diabetes. 2006 Dec;55(12):3494-500. |
pancreas insulin amount |
male |
60 days
| 6 |
|
199.0 |
ng/mg |
23.0 |
56.34 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68149 |
333 |
SS/Jr |
urine albumin excretion rate |
controlled sodium content diet (0.2 %) |
Poyan Mehr A, et al., Physiol Genomics 2003 Aug 15;14(3):209-16. |
urine albumin amount |
not specified |
98 days
| 6 |
|
253.07 |
mg/d |
|
|
enzyme linked immunosorbent assay |
urine |
0.0 |
|
0 |
|
rat albumin ELISA |
|
|
13278 |
335 |
GK/KyoSwe |
blood insulin level |
fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) |
Galli J, et al., NatGenet 1996 Jan;12(1):31-7. |
blood insulin amount |
not specified |
65 days
| 4 |
|
12.5 |
mU/l |
6.7 |
13.4 |
enzyme linked immunosorbent assay |
|
|
glucose injection |
0 |
min |
|
|
|
11389 |
82 |
MWF-Chr 6SHR/Rkb |
urine albumin excretion rate |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
urine albumin amount |
not specified |
98 days
| 19 |
|
48.8 |
mg/d |
41.7 |
181.77 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
65420 |
117 |
BN/Crl |
plasma insulin-like growth factor 1 level |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
blood insulin-like growth factor amount |
female |
60 days
| 6 |
|
665.0 |
ng/ml |
48.0 |
117.58 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68785 |
1012 |
GK/Ox |
plasma insulin-like growth factor 1 level |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
blood insulin-like growth factor amount |
female |
60 days
| 6 |
|
849.0 |
ng/ml |
76.0 |
186.16 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68787 |
1012 |
GK/Ox |
plasma corticosterone level |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
blood corticosterone amount |
female |
60 days
| 6 |
|
604.0 |
ng/ml |
65.0 |
159.22 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68791 |
1012 |
COP/OlaHsd |
plasma insulin level |
fasting (for 16 hours) |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
blood insulin amount |
not specified |
105 days
| 10 |
|
29.12 |
mU/l |
5.72 |
18.09 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68572 |
933 |
DA.F344-(D7Rat22-D7Mit2)/Nsi |
inflammatory exudate tumor necrosis factor level |
room temperature (14 ml) (for 3 days) then room temperature (10 ml) (for 3 days) then carrageenan (1 ml) (for 6 hours) |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
tumor necrosis factor amount |
female |
56 days-98 days |
9 |
|
899.0 |
pg/ml |
138.0 |
414.0 |
enzyme linked immunosorbent assay |
subcutaneous interscapular cavity |
0.0 |
|
0 |
|
hemocytometer |
inflammatory air pouch exudate Tnf level |
|
68401 |
332 |
F344/NHsd |
inflammatory exudate leukotriene B4 level |
room temperature (14 ml) (for 3 days) then room temperature (10 ml) (for 3 days) then carrageenan (1 ml) (for 6 hours) |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
eicosanoid amount |
female |
56 days-98 days |
9 |
median |
469.0 |
pg/ml |
|
|
enzyme linked immunosorbent assay |
subcutaneous interscapular cavity |
0.0 |
|
0 |
|
|
inflammatory exudate LTB4 measurement |
|
68407 |
332 |
F344.GK-(D1Rat175-D1Rat90)/Swe |
pancreas insulin level to pancreas total protein ratio |
control condition |
Granhall C, et al., Diabetes. 2006 Dec;55(12):3494-500. |
pancreas insulin amount |
male |
60 days
| 6 |
|
207.0 |
ng/mg |
21.0 |
51.44 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68146 |
333 |
DA/Bkl |
calculated serum anti-porcine type 2 collagen antibody titer |
type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) |
Griffiths MM, et al., Arthritis Rheum 2000 Jun;43(6):1278-89 |
blood immunoglobulin amount |
both |
66 days-126 days |
105 |
|
19.0 |
null |
0.59 |
6.0 |
enzyme linked immunosorbent assay |
|
0.0 |
immunized |
10 |
days |
variable |
titer |
|
69962 |
850 |
BN/SsN |
calculated serum anti-porcine type 2 collagen antibody titer |
type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) |
Griffiths MM, et al., Arthritis Rheum 2000 Jun;43(6):1278-89 |
blood immunoglobulin amount |
both |
66 days-126 days |
13 |
|
3.0 |
null |
0.55 |
2.0 |
enzyme linked immunosorbent assay |
|
0.0 |
immunized |
10 |
days |
variable |
titer |
|
69964 |
850 |
BB.SHR-(D6Rat184-D6Rat3)/K |
serum insulin level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
blood insulin amount |
both |
84 days
| 32 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
opthalmic venous plexus |
0.0 |
|
0 |
|
|
ng/ml is unit |
|
70099 |
324 |
SS-Leprem2Mcwi |
urine podocalyxin excretion rate |
physical restraint (20-30 min/d) (for 4 days) |
McPherson KC, et al., Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F793-F804. doi: 10.1152/ajprenal.00590.2015. Epub 2016 Jul 27. |
urine podocalyxin amount |
male |
42 days
| 6 |
|
64.0 |
ug/d |
14.0 |
34.29 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
100084 |
2418 |
SS-Leprem2Mcwi |
urine podocalyxin excretion rate |
physical restraint (20-30 min/d) (for 4 days) |
McPherson KC, et al., Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F793-F804. doi: 10.1152/ajprenal.00590.2015. Epub 2016 Jul 27. |
urine podocalyxin amount |
male |
126 days
| 6 |
|
247.0 |
ug/d |
62.0 |
151.87 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
100086 |
2418 |
GK |
plasma estradiol level |
sham surgical control condition (for 24 days) |
Apaijai N, et al., Biosci Rep. 2017 Oct 17;37(5). pii: BSR20170886. doi: 10.1042/BSR20170886. Print 2017 Oct 31. |
blood estradiol amount |
female |
87 days
| 6 |
|
49.6 |
pg/ml |
3.7 |
9.06 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
103775 |
2782 |
GK/Jcl |
serum insulin level |
control condition |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood insulin amount |
male |
52 days
| 6 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
103937 |
2884 |
SS/JrHsdMcwi |
plasma total cholesterol level |
control condition |
McPherson KC, et al., Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F793-F804. doi: 10.1152/ajprenal.00590.2015. Epub 2016 Jul 27. |
blood cholesterol amount |
male |
42 days
| 8 |
|
112.0 |
mg/dl |
5.0 |
14.14 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
100073 |
2418 |
SS/JrHsdMcwi |
plasma triglyceride level |
control condition |
McPherson KC, et al., Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F793-F804. doi: 10.1152/ajprenal.00590.2015. Epub 2016 Jul 27. |
blood triglyceride amount |
male |
126 days
| 6 |
|
1.86 |
mmol/l |
0.31 |
0.75 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
100077 |
2418 |
SS-Leprem2Mcwi |
plasma triglyceride level |
control condition |
McPherson KC, et al., Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F793-F804. doi: 10.1152/ajprenal.00590.2015. Epub 2016 Jul 27. |
blood triglyceride amount |
male |
126 days
| 7 |
|
17.52 |
mmol/l |
5.9 |
15.61 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
100078 |
2418 |
SD |
heart left ventricle interstitial epinephrine level during a period of time |
artificial aortocaval fistula (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle interstitial epinephrine amount |
male |
98 days
| 9 |
|
5.3 |
pg/hr |
0.9 |
2.7 |
enzyme linked immunosorbent assay |
|
0.0 |
ACF |
28 |
days |
|
heart left ventricle interstitial epinephrine level during a period of time |
|
99272 |
2278 |
SD |
plasma epinephrine level |
sham surgical control condition (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
blood epinephrine amount |
male |
98 days
| 8 |
|
83.0 |
pg/ml |
12.0 |
33.94 |
enzyme linked immunosorbent assay |
|
0.0 |
sham ACF |
28 |
days |
|
|
|
99287 |
2278 |
SD-Apoeem1Sage |
plasma corticosterone level |
control condition |
Ekuni D, et al., Lipids Health Dis. 2014 Sep 5;13:144. doi: 10.1186/1476-511X-13-144. |
blood corticosterone amount |
male |
56 days
| 7 |
|
14.2 |
ng/ml |
1.85 |
4.9 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
104493 |
2968 |
SD-Apoeem1Sage |
plasma corticosterone level |
removal of maxillary molar crown (for 56 days) |
Ekuni D, et al., Lipids Health Dis. 2014 Sep 5;13:144. doi: 10.1186/1476-511X-13-144. |
blood corticosterone amount |
male |
56 days
| 7 |
|
28.6 |
ng/ml |
4.69 |
12.4 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
104494 |
2968 |
SD-Apoeem1Sage |
serum C-reactive protein level |
control condition |
Ekuni D, et al., Lipids Health Dis. 2014 Sep 5;13:144. doi: 10.1186/1476-511X-13-144. |
C-reactive protein amount |
male |
56 days
| 7 |
|
1.0 |
mg/l |
0.04 |
0.1 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
104509 |
2968 |
SD |
intestine trypsin level |
vehicle control condition then acetic acid (for 0 hours) then physical restraint in tube type rodent restrainer (for 2 hours) then fasting (for 1 days) |
Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. |
intestine trypsin amount |
not specified |
0 days
| 4 |
|
0.17 |
ug/l |
0.01 |
0.01 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
error not defined |
|
105419 |
3015 |
F344/IcoCrlf |
number of individuals in a study population displaying Pasteurella pneumotropica infection at a point in time |
housing in trios (for 42 days) and housing with Pasteurella pneumotropica-infected subject (for 42 days) |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
female |
70 days-84 days |
6 |
|
5.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
pathogen |
42 |
days |
|
|
|
108628 |
3072 |
LEW/Crl |
number of individuals in a study population displaying Pasteurellaceae infection at a point in time |
housing in trios (for 42 days) and housing with Pasteurellaceae-infected subject (for 42 days) |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
female |
70 days-84 days |
6 |
|
1.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
pathogen |
42 |
days |
|
|
|
108634 |
3072 |
BUF/SimRijHsd |
number of individuals in a study population displaying Pasteurella pneumotropica infection at a point in time |
Haemophilus |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
not specified |
70 days-84 days |
8 |
|
4.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108608 |
3072 |
F344/IcoCrlf |
number of individuals in a study population displaying Haemophilus H21 infection at a point in time |
housing in trios (for 42 days) and housing with Haemophilus H21-infected subject (for 42 days) |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
female |
70 days-84 days |
6 |
|
4.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
pathogen |
42 |
days |
|
|
|
108618 |
3072 |
BDIX/Han |
number of individuals in a study population displaying Haemophilus H35 infection at a point in time |
housing in trios (for 42 days) and housing with Haemophilus H35-infected subject (for 42 days) |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
female |
70 days-84 days |
6 |
|
3.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
pathogen |
42 |
days |
|
|
|
108621 |
3072 |
Slc:ZUC-Leprfa+ |
plasma insulin level |
fasting (for 17 hours) |
Mine T, etal., Biol Pharm Bull. 2002 Nov;25(11):1412-6. doi: 10.1248/bpb.25.1412. |
blood insulin amount |
male |
84 days-105 days |
9 |
|
26.0 |
mU/l |
2.6 |
7.8 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
enzyme immunoassay (MMO:0000713) |
slc:zuc-leprfa+ |
|
108658 |
3070 |
SHR-Chr 8MWF/Rkb |
urine albumin excretion rate |
unilateral nephrectomy (for 126 days) |
Schulz A, etal., Physiol Genomics. 2012 Jan 18;44(1):110-6. Epub 2011 Nov 22. |
urine albumin amount |
male |
168 days
| 15 |
|
37.2 |
mg/d |
4.9 |
18.98 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
109565 |
3148 |
GK/Jpe |
urine 8-hydroxy-2'-deoxyguanosine level |
controlled cocoa butter content diet (7.5 %) (for 90 days) and controlled cholesterol content diet (1.25 %) (for 90 days) and soybean oil (2 ml/kg) (for 90 days) then fasting (for 15 hours) |
Sena CM, etal., Int J Mol Sci. 2018 Sep 11;19(9). pii: ijms19092706. doi: 10.3390/ijms19092706. |
urine molecular composition trait |
male |
540 days
| 7 |
|
302.37 |
ng/d |
42.34 |
112.02 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
110929 |
3193 |
MWF/FubRkb |
urine albumin excretion rate |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
urine albumin amount |
not specified |
100 days
| 0 |
|
58.1 |
mg/d |
5.8 |
|
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108108 |
3115 |
GK/MolTac |
serum insulin level |
fasting (for 6 hours) |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood insulin amount |
female |
60 days
| 6 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
fasting insulin, non fasting insulin |
106923 |
3071 |
GK/MolTac |
serum insulin level |
fasting (for 6 hours) |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood insulin amount |
female |
420 days
| 11 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
fasting insulin, non fasting insulin |
106925 |
3071 |
GK |
plasma glucagon-like peptide 1 level |
fasting (for 16 hours) |
Weng S, etal., Obes Surg. 2017 Mar;27(3):657-664. doi: 10.1007/s11695-016-2320-z. |
blood glucagon-like peptide amount |
male |
77 days
| 10 |
|
2.66 |
ng/ml |
0.09 |
0.3 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
plasma glucagon-like peptide 1 level (CMO:0003638) |
|
109081 |
3111 |
GK |
plasma gastric inhibitory polypeptide level |
fasting (for 16 hours) |
Weng S, etal., Obes Surg. 2017 Mar;27(3):657-664. doi: 10.1007/s11695-016-2320-z. |
blood gastric inhibitory polypeptide amount |
male |
77 days
| 10 |
|
6.09 |
pg/ml |
0.9 |
2.84 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
plasma gastric inhibitory polypeptide level (CMO:0003641) |
|
109086 |
3111 |
LEW/HanHfr |
number of individuals in a study population displaying Haemophilus H21 infection at a point in time |
Haemophilus |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
not specified |
70 days-84 days |
8 |
|
6.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
107796 |
3072 |
WAG/Nov |
kidney cortex hyaluronic acid level |
controlled sucrose content drinking water (4 %) (for 2 days) and solid food deprivation (for 2 days) |
Ivanova LN, et al., Exp Physiol. 2013 Nov;98(11):1608-19. doi: 10.1113/expphysiol.2013.073163. Epub 2013 Aug 16. |
kidney molecular composition trait |
not specified |
0 days
| 4 |
|
0.88 |
mg/g |
0.21 |
0.42 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
107213 |
3078 |
Jcl:WI |
serum insulin level |
vildagliptin (30 mg/kg/d) (for 106 days) then fasting |
Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5. |
blood insulin amount |
male |
154 days
| 7 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
110214 |
3167 |
GK/Jcl |
serum insulin level |
fasting |
Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5. |
blood insulin amount |
male |
154 days
| 7 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
110215 |
3167 |
Jcl:WI |
serum insulin level |
fasting then glucose solution (2 g/kg) (for 0.5 hours) |
Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5. |
blood insulin amount |
male |
140 days
| 7 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
glucose |
30 |
min |
|
|
|
110217 |
3167 |
Jcl:WI |
serum glucagon-like peptide 1 level |
vildagliptin (30 mg/kg/d) (for 106 days) then fasting |
Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5. |
blood glucagon-like peptide amount |
male |
154 days
| 7 |
|
42.6 |
pg/ml |
1.99 |
5.27 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
110222 |
3167 |
GK/Jcl |
serum glucagon-like peptide 1 level |
fasting |
Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5. |
blood glucagon-like peptide amount |
male |
154 days
| 7 |
|
21.5 |
pg/ml |
3.55 |
9.39 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
110223 |
3167 |
WAG/Nov |
kidney cortex hyaluronic acid level |
desmopressin (100 ug/kg) (for 2 days) |
Ivanova LN, et al., Exp Physiol. 2013 Nov;98(11):1608-19. doi: 10.1113/expphysiol.2013.073163. Epub 2013 Aug 16. |
kidney molecular composition trait |
not specified |
0 days
| 4 |
|
0.69 |
mg/g |
0.12 |
0.24 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
107214 |
3078 |
MWF/FubRkb |
urine albumin excretion rate |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
urine albumin amount |
male |
44 days
| 5 |
|
18.4 |
mg/d |
4.65 |
10.4 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
109717 |
3152 |
MWF/FubRkb |
urine albumin excretion rate |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
urine albumin amount |
female |
58 days
| 5 |
|
9.5 |
mg/d |
2.95 |
6.6 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
109720 |
3152 |
MWF/FubRkb |
urine albumin excretion rate |
control condition |
Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. |
urine albumin amount |
male |
84 days
| 10 |
|
46.2 |
mg/d |
4.0 |
12.65 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
109286 |
3141 |
MWF/FubRkb |
urine albumin excretion rate |
left nephrectomy (for 84 days) |
Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. |
urine albumin amount |
not specified |
84 days
| 15 |
|
124.1 |
mg/d |
10.9 |
42.22 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
109661 |
3149 |
HsdCpb:WU |
urine albumin excretion rate |
left nephrectomy (for 84 days) then controlled ramipril content drinking water (1 ml/kg/d) (between 28 and 4 days) |
Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. |
urine albumin amount |
not specified |
84 days
| 15 |
|
0.1 |
mg/d |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
109662 |
3149 |
SD-Ldlrem1Sage |
plasma plasminogen activator inhibitor 1 level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood plasminogen activator inhibitor 1 amount |
male |
448 days
| 8 |
|
10.36 |
ng/ml |
0.49 |
1.39 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
138307 |
3201 |
Hsd:SD |
plasma plasminogen activator inhibitor 1 level |
controlled fat content diet (42 %) (for 364 days) |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood plasminogen activator inhibitor 1 amount |
male |
448 days
| 10 |
|
12.86 |
ng/ml |
1.6 |
5.06 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
138308 |
3201 |
SD-Ldlrem1Sage |
blood fibrinogen level |
controlled fat content diet (42 %) (for 364 days) |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
fibrin formation trait |
male |
448 days
| 16 |
|
3.21 |
mg/ml |
0.32 |
1.28 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
138313 |
3201 |
Hsd:SD |
plasma leptin level |
controlled fat content diet (42 %) (for 364 days) |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood leptin amount |
male |
448 days
| 10 |
|
34.72 |
ng/ml |
2.72 |
8.6 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
138316 |
3201 |
WAG/Nov |
kidney papilla hyaluronic acid level |
controlled sucrose content drinking water (4 %) (for 2 days) and solid food deprivation (for 2 days) |
Ivanova LN, et al., Exp Physiol. 2013 Nov;98(11):1608-19. doi: 10.1113/expphysiol.2013.073163. Epub 2013 Aug 16. |
kidney molecular composition trait |
not specified |
0 days
| 4 |
|
13.6 |
mg/g |
0.1 |
0.2 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
107218 |
3078 |
SS/Jr |
urine albumin excretion rate |
controlled sodium content diet (0.2 %) |
Poyan Mehr A, et al., Physiol Genomics 2003 Aug 15;14(3):209-16. |
urine albumin amount |
not specified |
28 days
| 12 |
|
4.7 |
mg/d |
|
|
enzyme linked immunosorbent assay |
urine |
0.0 |
|
0 |
|
rat albumin ELISA |
|
|
13281 |
335 |
BN/SsN |
calculated serum anti-rat type 2 collagen autoantibody titer |
type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) |
Griffiths MM, et al., Arthritis Rheum 2000 Jun;43(6):1278-89 |
blood autoantibody amount |
both |
66 days-126 days |
13 |
|
2.0 |
null |
0.55 |
2.0 |
enzyme linked immunosorbent assay |
|
0.0 |
immunized |
10 |
days |
variable |
titer |
|
69965 |
850 |
DA/BklArbNsi |
inflammatory exudate leukotriene B4 level |
room temperature (14 ml) (for 3 days) then room temperature (10 ml) (for 3 days) then carrageenan (1 ml) (for 6 hours) |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
eicosanoid amount |
female |
56 days-98 days |
9 |
median |
250.0 |
pg/ml |
|
|
enzyme linked immunosorbent assay |
subcutaneous interscapular cavity |
0.0 |
|
0 |
|
|
inflammatory exudate LTB4 measurement |
|
68406 |
332 |
F344/NHsd |
inflammatory exudate lipoxin A4 level |
room temperature (14 ml) (for 3 days) then room temperature (10 ml) (for 3 days) then carrageenan (1 ml) (for 6 hours) |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
eicosanoid amount |
female |
56 days-98 days |
8 |
median |
41.0 |
pg/ml |
|
|
enzyme linked immunosorbent assay |
subcutaneous interscapular cavity |
0.0 |
|
0 |
|
|
inflammatory exudate LXA4 measurementasurement |
|
68409 |
332 |
GK/Ox |
plasma prolactin level |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
blood prolactin amount |
female |
60 days
| 6 |
|
133.0 |
ng/ml |
33.0 |
80.83 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68795 |
1012 |
GK/Ox |
plasma growth hormone level |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
blood growth hormone amount |
male |
60 days
| 6 |
|
66.0 |
ng/ml |
3.0 |
7.35 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68782 |
1012 |
BBDR/Rhw |
calculated serum anti-rat type 2 collagen autoantibody titer |
Freund's incomplete adjuvant (50 %) and type II collagen (2 mg/kg) |
Furuya T, et al., Hum Mol Genet 2000 Sep 22;9(15):2241-50 |
blood autoantibody amount |
male |
66 days-126 days |
11 |
|
30.6 |
null |
1.51 |
5.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
titer |
|
69925 |
1241 |
GK/MolTac |
serum insulin level |
control condition |
Korkmaz-Ic�z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. |
blood insulin amount |
male |
112 days
| 8 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
102943 |
2783 |
SD |
plasma norepinephrine level |
sham surgical control condition (for 105 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
blood norepinephrine amount |
male |
175 days
| 8 |
|
102.0 |
pg/ml |
16.0 |
45.25 |
enzyme linked immunosorbent assay |
|
0.0 |
sham ACF |
105 |
days |
|
|
|
99285 |
2278 |
SD |
plasma epinephrine level |
artificial aortocaval fistula (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
blood epinephrine amount |
male |
98 days
| 9 |
|
91.0 |
pg/ml |
21.0 |
63.0 |
enzyme linked immunosorbent assay |
|
0.0 |
ACF |
28 |
days |
|
|
|
99288 |
2278 |
SS.ZUC-Leprfa+/+/Slc |
serum insulin level |
fasting (for 16 hours) |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
blood insulin amount |
male |
126 days
| 6 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
101915 |
2642 |
F344/DuCrlCrlj |
serum insulin level |
fasting (between 6 and 7 hours) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood insulin amount |
male |
185 days
| 9 |
|
0.02 |
mg/dl |
0.0 |
0.01 |
enzyme linked immunosorbent assay |
tail vein |
0.0 |
|
0 |
|
|
|
|
67644 |
85 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
serum leptin level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood leptin amount |
male |
211 days
| 11 |
|
6.28 |
ng/ml |
0.51 |
1.69 |
enzyme linked immunosorbent assay |
|
0.0 |
oral glucose |
7 |
days |
ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) |
|
|
67485 |
311 |
MWF/FubRkb |
urine albumin excretion rate |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
urine albumin amount |
not specified |
56 days
| 18 |
|
18.1 |
mg/d |
2.0 |
8.49 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
65273 |
117 |
MWF-Chr 6SHR/Rkb |
urine albumin excretion rate |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
urine albumin amount |
not specified |
168 days
| 19 |
|
16.6 |
mg/d |
15.2 |
66.26 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
65276 |
117 |
BN/Crl |
plasma corticosterone level |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
blood corticosterone amount |
female |
60 days
| 6 |
|
441.0 |
ng/ml |
67.0 |
164.12 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68789 |
1012 |
GK/Ox |
plasma prolactin level |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
blood prolactin amount |
male |
60 days
| 6 |
|
7.0 |
ng/ml |
2.0 |
4.9 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68794 |
1012 |
GK/Ox |
plasma growth hormone level |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
blood growth hormone amount |
female |
60 days
| 6 |
|
66.0 |
ng/ml |
23.0 |
56.34 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68783 |
1012 |
DA.F344-(D8Arb15-D8Arb22)/Arb |
inflammatory exudate tumor necrosis factor level |
room temperature (14 ml) (for 3 days) then room temperature (10 ml) (for 3 days) then carrageenan (1 ml) (for 6 hours) |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
tumor necrosis factor amount |
female |
56 days-98 days |
11 |
|
1570.0 |
pg/ml |
240.0 |
795.99 |
enzyme linked immunosorbent assay |
subcutaneous interscapular cavity |
0.0 |
|
0 |
|
hemocytometer |
inflammatory air pouch exudate Tnf level |
|
68402 |
332 |
F344/NHsd |
inflammatory exudate leukotriene B4 level to lipoxin A4 level ratio |
room temperature (14 ml) (for 3 days) then room temperature (10 ml) (for 3 days) then carrageenan (1 ml) (for 6 hours) |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
eicosanoid amount |
female |
56 days-98 days |
9 |
|
11.4 |
null |
|
|
enzyme linked immunosorbent assay |
subcutaneous interscapular cavity |
0.0 |
|
0 |
|
|
inflammatory exudate LTB4 to LXA4 ratio |
|
68411 |
332 |
SS/JrHsdMcwi |
plasma insulin level |
control condition |
McPherson KC, et al., Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F793-F804. doi: 10.1152/ajprenal.00590.2015. Epub 2016 Jul 27. |
blood insulin amount |
male |
42 days
| 8 |
|
7.8 |
mU/l |
0.78 |
2.21 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
100091 |
2418 |
GK/Jcl |
serum insulin level |
controlled hesperidin content diet (1 %) (for 28 days) |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood insulin amount |
male |
52 days
| 6 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
103938 |
2884 |
GK/Jcl |
serum insulin level |
controlled cyclodextrin (CD)-clathrated hesperetin content diet (4.6 %) (for 28 days) |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood insulin amount |
male |
52 days
| 6 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
103939 |
2884 |
GK/Jcl |
serum adiponectin level |
control condition |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood adiponectin amount |
male |
52 days
| 6 |
|
10.38 |
ng/ml |
1.62 |
3.97 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
103941 |
2884 |
GK/Jcl |
liver triglyceride level |
controlled cyclodextrin (CD)-clathrated hesperetin content diet (4.6 %) (for 28 days) |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
liver triglyceride amount |
male |
52 days
| 6 |
|
9.41 |
mg/g |
0.8 |
1.96 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
103973 |
2884 |
SD |
heart left ventricle interstitial norepinephrine level during a period of time |
sham surgical control condition (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle interstitial norepinephrine amount |
male |
98 days
| 8 |
|
6.2 |
pg/hr |
1.0 |
2.83 |
enzyme linked immunosorbent assay |
|
0.0 |
sham ACF |
28 |
days |
|
heart left ventricle interstitial bradykinin level during a period of time |
|
99267 |
2278 |
SD |
heart left ventricle interstitial epinephrine level during a period of time |
sham surgical control condition (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle interstitial epinephrine amount |
male |
98 days
| 8 |
|
3.5 |
pg/hr |
0.3 |
0.85 |
enzyme linked immunosorbent assay |
|
0.0 |
sham ACF |
28 |
days |
|
heart left ventricle interstitial epinephrine level during a period of time |
|
99271 |
2278 |
SD |
heart left ventricle interstitial epinephrine level during a period of time |
sham surgical control condition (for 105 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle interstitial epinephrine amount |
male |
175 days
| 8 |
|
3.5 |
pg/hr |
0.4 |
1.13 |
enzyme linked immunosorbent assay |
|
0.0 |
sham ACF |
105 |
days |
|
heart left ventricle interstitial epinephrine level during a period of time |
|
99273 |
2278 |
SD |
plasma norepinephrine level |
sham surgical control condition (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
blood norepinephrine amount |
male |
98 days
| 8 |
|
93.0 |
pg/ml |
12.0 |
33.94 |
enzyme linked immunosorbent assay |
|
0.0 |
sham ACF |
28 |
days |
|
pl bk |
|
99283 |
2278 |
SS.ZUC-Leprfa+/+/Slc |
serum leptin level |
fasting (for 16 hours) |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
blood leptin amount |
male |
126 days
| 6 |
|
1.67 |
ng/ml |
0.37 |
0.91 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
101911 |
2642 |
SS.ZUC-Leprfa-/-/Slc |
serum leptin level |
fasting (for 16 hours) |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
blood leptin amount |
male |
126 days
| 7 |
|
53.97 |
ng/ml |
2.34 |
6.19 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
101912 |
2642 |
SS.ZUC-Leprfa-/-/Slc |
serum insulin level |
fasting (for 16 hours) |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
blood insulin amount |
male |
126 days
| 7 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
101916 |
2642 |
SD-Apoeem1Sage |
serum oxidized LDL level |
removal of maxillary molar crown (for 56 days) |
Ekuni D, et al., Lipids Health Dis. 2014 Sep 5;13:144. doi: 10.1186/1476-511X-13-144. |
serum oxidized LDL amount |
male |
56 days
| 7 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
104506 |
2968 |
SD-Lepem1Sage+/+ |
plasma insulin level |
fasting (for 4 hours) |
D'souza AM, et al., Endocrinology. 2014 Apr;155(4):1268-79. doi: 10.1210/en.2013-1523. Epub 2014 Jan 27. |
blood insulin amount |
male |
42 days
| 6 |
|
14.82 |
mU/l |
3.12 |
7.64 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
104454 |
2949 |
SD |
serum interleukin-9 level |
control condition |
Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. |
blood interleukin-9 amount |
not specified |
0 days
| 8 |
|
0.08 |
ug/l |
0.0 |
0.01 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
error not defined |
|
105414 |
3015 |
SD |
serum interleukin-9 level |
acetic acid (for 0 hours) then physical restraint in tube type rodent restrainer (for 2 hours) then fasting (for 1 days) |
Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. |
blood interleukin-9 amount |
not specified |
0 days
| 12 |
|
0.08 |
ug/l |
0.0 |
0.01 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
error not defined |
|
105416 |
3015 |
LEW/HanHfr |
number of individuals in a study population displaying Haemophilus H35 infection at a point in time |
Haemophilus |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
not specified |
70 days-84 days |
8 |
|
7.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108604 |
3072 |
WAG/RijHfr |
number of individuals in a study population displaying Haemophilus H35 infection at a point in time |
Haemophilus |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
not specified |
70 days-84 days |
8 |
|
8.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108605 |
3072 |
LEW/Crl |
number of individuals in a study population displaying Haemophilus H35 infection at a point in time |
housing in trios (for 42 days) and housing with Haemophilus H35-infected subject (for 42 days) |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
female |
70 days-84 days |
6 |
|
2.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
pathogen |
42 |
days |
|
|
|
108624 |
3072 |
GK/MolTac |
serum insulin level |
control condition |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood insulin amount |
female |
60 days
| 6 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
fasting insulin, non fasting insulin |
106917 |
3071 |
GK/MolTac |
serum insulin level |
control condition |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood insulin amount |
female |
240 days
| 11 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
fasting insulin, non fasting insulin |
106918 |
3071 |
WKY/NMolTac |
serum insulin level |
control condition |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood insulin amount |
female |
240 days
| 9 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
fasting insulin, non fasting insulin |
106921 |
3071 |
GK/MolTac |
serum insulin level |
fasting (for 6 hours) |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood insulin amount |
female |
240 days
| 11 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
fasting insulin, non fasting insulin |
106924 |
3071 |
Slc:ZUC-Leprfa-/- |
plasma insulin level |
fasting (for 17 hours) |
Mine T, etal., Biol Pharm Bull. 2002 Nov;25(11):1412-6. doi: 10.1248/bpb.25.1412. |
blood insulin amount |
male |
84 days-105 days |
44 |
|
384.8 |
mU/l |
41.6 |
275.94 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
enzyme immunoassay (MMO:0000713) |
slc:zuc-leprfa-/- |
|
106938 |
3070 |
BDIX/Han |
number of individuals in a study population displaying Pasteurellaceae infection at a point in time |
housing in trios (for 42 days) and housing with Pasteurellaceae-infected subject (for 42 days) |
Boot R, et al., Lab Anim. 2005 Oct;39(4):413-20. doi: 10.1258/002367705774286457. |
response to bacterial infection trait |
female |
70 days-84 days |
6 |
|
4.0 |
null |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
pathogen |
42 |
days |
|
|
|
108631 |
3072 |
SHR-Chr 8MWF/Rkb |
urine albumin excretion rate |
sham surgical control condition (for 42 days) |
Schulz A, etal., Physiol Genomics. 2012 Jan 18;44(1):110-6. Epub 2011 Nov 22. |
urine albumin amount |
male |
84 days
| 9 |
|
1.3 |
mg/d |
0.2 |
0.6 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
109564 |
3148 |
GK |
plasma glucagon-like peptide 1 level |
fasting (for 16 hours) |
Weng S, etal., Obes Surg. 2017 Mar;27(3):657-664. doi: 10.1007/s11695-016-2320-z. |
blood glucagon-like peptide amount |
male |
77 days
| 10 |
|
2.77 |
ng/ml |
0.18 |
0.58 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
plasma glucagon-like peptide 1 level (CMO:0003638) |
|
109079 |
3111 |
GK |
plasma glucagon-like peptide 1 level |
fasting (for 16 hours) |
Weng S, etal., Obes Surg. 2017 Mar;27(3):657-664. doi: 10.1007/s11695-016-2320-z. |
blood glucagon-like peptide amount |
male |
77 days
| 10 |
|
2.77 |
ng/ml |
0.22 |
0.7 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
plasma glucagon-like peptide 1 level (CMO:0003638) |
|
109080 |
3111 |
GK |
plasma insulin level |
fasting (for 16 hours) |
Weng S, etal., Obes Surg. 2017 Mar;27(3):657-664. doi: 10.1007/s11695-016-2320-z. |
blood insulin amount |
male |
77 days
| 10 |
|
11.96 |
mU/l |
0.33 |
1.04 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
plasma glucagon-like peptide 1 level (CMO:0003638) |
|
109082 |
3111 |
GK |
plasma insulin level |
fasting (for 16 hours) |
Weng S, etal., Obes Surg. 2017 Mar;27(3):657-664. doi: 10.1007/s11695-016-2320-z. |
blood insulin amount |
male |
77 days
| 10 |
|
11.44 |
mU/l |
0.16 |
0.52 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
plasma glucagon-like peptide 1 level (CMO:0003638) |
|
109083 |
3111 |
GK |
serum insulin level |
vildagliptin (30 mg/kg/d) (for 106 days) then fasting |
Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5. |
blood insulin amount |
male |
154 days
| 7 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
110216 |
3167 |
Jcl:WI |
serum insulin level |
vildagliptin (30 mg/kg/d) (for 92 days) then fasting then glucose solution (2 g/kg) (for 0.5 hours) |
Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5. |
blood insulin amount |
male |
140 days
| 7 |
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
glucose |
30 |
min |
|
|
|
110220 |
3167 |
MWF/FubRkb |
urine albumin excretion rate |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
urine albumin amount |
female |
44 days
| 5 |
|
11.7 |
mg/d |
4.47 |
10.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
109718 |
3152 |
MWF/FubRkb |
urine albumin excretion rate |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
urine albumin amount |
male |
58 days
| 5 |
|
20.07 |
mg/d |
3.0 |
6.7 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
109719 |
3152 |
SHR-Chr 6MWF/Rkb |
urine albumin excretion rate |
control condition |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
urine albumin amount |
male |
168 days
| 10 |
|
0.6 |
mg/d |
0.1 |
0.32 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108128 |
3116 |
MWF/FubRkb |
urine albumin excretion rate |
left nephrectomy (for 84 days) then controlled ramipril content drinking water (1 ml/kg/d) (between 28 and 4 days) |
Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. |
urine albumin amount |
not specified |
84 days
| 15 |
|
46.6 |
mg/d |
7.7 |
29.82 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
109663 |
3149 |
SHR-Chr 6MWF/Rkb |
urine albumin excretion rate |
controlled NG-nitroarginine methyl ester content drinking water (5 mg/kg/d) (for 42 days) |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
urine albumin amount |
male |
84 days
| 10 |
|
12.7 |
mg/d |
3.5 |
11.07 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108130 |
3116 |
SD-Ldlrem1Sage |
plasma interleukin-6 level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood interleukin-6 amount |
male |
448 days
| 10 |
|
140.0 |
pg/ml |
56.0 |
177.09 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
138351 |
3201 |
SD-Ldlrem1Sage |
blood interleukin-4 level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood interleukin-4 amount |
male |
448 days
| 8 |
|
11.0 |
pg/ml |
2.0 |
5.66 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
138361 |
3201 |
SD-Ldlrem1Sage |
plasma interleukin-6 level |
controlled fat content diet (42 %) |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood interleukin-6 amount |
male |
448 days
| 16 |
|
307.0 |
pg/ml |
25.0 |
100.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
138352 |
3201 |
SD-Ldlrem1Sage |
blood fibrinogen level |
standard diet |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
fibrin formation trait |
male |
448 days
| 8 |
|
2.87 |
mg/ml |
0.17 |
0.47 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
138311 |
3201 |
Hsd:SD |
plasma adiponectin level |
controlled fat content diet (42 %) (for 364 days) |
Sithu SD, etal., JCI Insight. 2017 May 4;2(9). pii: 86442. doi: 10.1172/jci.insight.86442. |
blood adiponectin amount |
male |
448 days
| 10 |
|
83.97 |
ug/ml |
5.17 |
16.35 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
138320 |
3201 |
MWF/FubRkb |
urine albumin excretion rate |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
urine albumin amount |
female |
56 days
| 18 |
|
5.2 |
mg/d |
0.9 |
3.82 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
108969 |
3133 |
SHR/FubRkb |
urine albumin excretion rate |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
urine albumin amount |
not specified |
56 days
| 10 |
|
0.3 |
mg/d |
0.1 |
0.32 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
65271 |
117 |
MWF-Chr 6SHR/Rkb |
urine albumin excretion rate |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
urine albumin amount |
not specified |
98 days
| 19 |
|
2.9 |
mg/d |
3.5 |
15.26 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
65274 |
117 |
F344/DuCrlSwe |
pancreas insulin level to pancreas total protein ratio |
control condition |
Granhall C, et al., Diabetes. 2006 Dec;55(12):3494-500. |
pancreas insulin amount |
male |
60 days
| 6 |
|
204.0 |
ng/mg |
21.0 |
51.44 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
68144 |
333 |
GK |
plasma insulin level |
sham surgical control condition (for 24 days) |
Apaijai N, et al., Biosci Rep. 2017 Oct 17;37(5). pii: BSR20170886. doi: 10.1042/BSR20170886. Print 2017 Oct 31. |
blood insulin amount |
female |
87 days
| 6 |
|
26.0 |
mU/l |
2.6 |
6.37 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
103763 |
2782 |
SS/JrHsdMcwi |
plasma triglyceride level |
control condition |
McPherson KC, et al., Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F793-F804. doi: 10.1152/ajprenal.00590.2015. Epub 2016 Jul 27. |
blood triglyceride amount |
male |
42 days
| 9 |
|
0.46 |
mmol/l |
0.07 |
0.2 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
|
100075 |
2418 |